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Liver disease is a leading cause of mortality in the United States. Tissue engineering and
regenerative medicine (TE&RM) approaches to treating liver disease have the potential to
provide temporary support with biohybrid liver-assist devices or long term therapy by replacing
the diseased liver with functional constructs. A rate-limiting step for TE&RM strategies has been
the loss of hepatocyte-specific functions after hepatocytes are isolated from their highly
specialized in vivo microenvironment and placed in in vitro culture systems. The identification
of a biologic substrate that can maintain a functional hepatocyte differentiation profile during in
vitro culture would advance potential TE&RM therapeutic strategies.
The present study is predicated upon the hypothesis that the substrate upon which
hepatocytes are seeded is a critical determinant of cell phenotype and function. Biologic
scaffolds composed of extracellular matrix (ECM) derived from mammalian organs have been
used to maintain cell phenotype in vitro. Two studies were performed to evaluate the ability of
ECM scaffolds to maintain primary human hepatocyte (PHH) phenotype in vitro. The first study
evaluated the effect of ECM scaffolds derived from porcine liver (PLECM) and human liver
(HLECM) upon maintainence of PHH specific functions in vitro. Cytochrome P450 activity and
albumin secretion were used as indicators of hepatocyte functionality. No differences in
hepatoycte-specific functions were measured when comparing PHH cultured with PLECM and
HLECM. From a clinical perspective, the results are appealing because of the limited
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vavailability of human liver tissue compared to porcine liver tissue for the manufacture of ECM
scaffolds.
The second study cultured PHH between two layers of PLECM and compared with
Matrigel double gel cultures and adsorbed type-1 collagen. Albumin secretion, hepatic transport
activity and ammonia metabolism were used as markers of hepatocyte functionality. PHH
cultured between two layers of porcine liver ECM had significantly higher levels of albumin
secretion, hepatic transport activity, and ammonia metabolism compared to PHH cultured on
collagen.
vi
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11.0 INTRODUCTION
1.1 THE MAMMALIAN LIVER
The liver is the largest internal organ and is responsible for over 500 functions essential for life.
Hepatocytes are the major cells of the liver. The non-parenchymal cells of the liver include
sinusoidal endothelial cells, stellate cells, Ito cells, and Kuppfer cells. The NPCs work in concert
with hepatocytes to maintain many life-essential functions, including the following: synthesizing
of a myriad of proteins essential for the blood coagulation cascade and the immune response;
regulating the levels of many chemicals found in the bloodstream; storing and catabolizing
glycogen; metabolizing drugs, toxins, hemoglobin, and ammonia; aiding the body in fat
digestion by production of bile; storing reserves of vitamins, minerals, and nutrients; and
detoxifying blood of poisons and wastes.
1.2 HEPATOCYTES
Hepatocytes are the parenchymal cells of the liver and account for approximately 80% of
all liver cells [1, 2]. Hepatocytes perform hundreds of functions essential for liver function,
which include but are not limited to:
2 Metabolize drugs and steroids by cytochrome P450s. CYP3A4 & CYP1A
comprise 60-90% of the total CYP proteins in human liver and measurement of
basal and induced levels of drug metabolizing enzymes indicate maintainence of
hepatocyte functionality
 Synthesize many important proteins, including albumin
 Detoxify ammonia from the blood by metabolizing ammonia into urea for
excretion
 Production of bile salts (sodium taurocholate)
1.3 HEPATIC EXTRACELLULAR MATRIX
ECM proteins are distributed in varying amounts throughout the normal liver. ECM
proteins in the liver include the collagens (mainly type-I collagen and minor quantities of types
III, IV, V, and VI), fibronectin, vitronectin, tenascin, elastin, proteoglycans, ECM-bound growth
factors, and small amounts of laminin [3].
31.4 LIVER DISEASE
Liver disease is the eleventh leading cause of mortality and results in approximately
30,000 deaths per year in the United States [4]. Approximately 17,000 patients are on the liver
transplant waiting list, and about 10,000 patients are added to the list each year, with ~2,500
deaths per year [5]. Chronic liver diseases include metabolic liver disease, alcoholic liver
disease, hepatitis, portal hypertension, hemachromatosis, cholestasis, steatosis, Gaucher disease,
liver cancer, and primary biliary cirrhosis. Chronic liver diseases account for approximately 80%
of the deaths because the patients are too ill to tolerate liver transplantation. Acute liver failure
due to ischemia/reperfusion injury, idiosyncratic drug reaction, acetaminophen poisoning,
alcohol poisoning, and viral hepatitis represents the remaining 20% of the deaths [6].
1.5 LIVER DISEASE THERAPIES
Allogeneic liver transplantation is the “gold standard” treatment of choice for patients
with end-stage liver disease but is limited by its high cost and the severe donor organ shortage.
Both xenotransplantation and hepatocyte transplantation represent alternative therapies but the
technologies have had limited clinical success [7, 8]. Xenotransplantation could provide a
limitless supply of donor organs; however, previous attempts have resulted in hyperacute
rejection and death [9]. Hepatocyte transplantation offers much promise for correcting non-
emergency conditions such as genetic defects of the liver [10, 11] but several stumbling blocks
have limited its clinical success. Low efficiency of engraftment, long-term immunosuppression
from the use of allogeneic cells, and a lag time of 48 hours for the transplanted hepatocytes to
4become functional in vivo, which is too long in a rapidly deteriorating patient, have hindered the
advancement of hepatocyte transplantation.
Biohybrid artificial liver (BAL) provides temporary support for patients waiting for an
allogeneic liver transplant and since the liver can regenerate, the temporary support provided by
BAL may allow time for the liver to regenerate. However, the lack of reliable cell source
combined with the inability of BAL to maintain the functionality of hepatocytes for long periods
of time have hindered its clinical success.
52.0 TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Tissue engineering and regenerative medicine approaches to treating liver disease may
alleviate the crisis by providing temporary liver support with biohybrid artificial liver-assist
devices or by replacing the function of the diseased liver with tissue-engineered constructs
utilizing a combination of cells, scaffolds and bioactive factors that are implanted into the body
[12, 13]. Additionally, tissue engineered scaffolds that maintain hepatocyte functionality in vitro
could be used to develop in vitro models to study drug metabolism or the pathophysiology of
liver disease [14, 15]
A common regenerative medicine strategy for tissue and organ reconstruction involves
the seeding of a scaffold with cells harvested from the tissues or organs of interest, followed by
eventual placement of the cell-scaffold combination to the intended in vivo location. Cells that
are isolated from their native microenvironment dedifferentiate and the rate of dedifferentiation
is dependent on the microenvironment, of which the substrate or scaffold is of paramount
importance [16, 17]. Loss of in vivo microenvironmental signals such as paracrine interactions
(cell-cell), physical-chemical factors (i.e. oxygen tension, metabolites), mechanical stimuli
(blood flow), and cell-extracellular matrix interactions result in dedifferentiation and the effects
of dedifferentiation following seeding upon various scaffolds of the constructs are largely
unknown but logically would detract from optimal function [18].
6The development of therapies to treat liver disease is an intense area of research that has
spanned several decades but the progress has been limited. The success of tissue engineering and
regenerative medicine therapies depend upon the ability to provide a microenvironment that
supports the viability of hepatocytes with maintainence of liver-specific functions both in vitro
and in vivo. As the field of tissue engineering and regenerative medicine moves toward the
replacement of more complex tissues and three-dimensional organs, such as the liver or heart, it
is likely that more specialized scaffolds will be needed to support multiple, functional cell
phenotypes in site-specific, unique three-dimensional arrangements.
A myriad of scaffolds have been used to culture hepatocytes in vitro with the ultimate
goal of maintaining the functionality and viability of a large mass of isolated hepatocytes for
more than several weeks. Substrates used for hepatoycte culture range from synthetic polymers
(e.g. polylactic acid, polyglycolic acid, and poly(ethylene glycol) (PEG) hydrogels) [13, 14, 19-
21] to naturally-derived materials (e.g. collagen, alginate, chitosan) [22-25] and complex
extracellular matrix (ECM) substrata (e.g. Matrigel (MG) or ECM derived from rat or porcine
liver) [26-28]. The ideal scaffold upon which the cells are seeded or to which they are recruited
must sustain the biological processes of the cells, including cell attachment, migration,
differentiation, and self-assembly of groups of cells. Further, the scaffold material must have
physical and material properties that will support clinical utility (e.g., surgical manipulation,
suture retention strength, and local tissue mechanical forces) and ideally would degrade at an
appropriate rate while new matrix is deposited and tissue remodeling occurs.
72.1 USE OF BIOLOGIC EXTRACELLULAR MATRIX SCAFFOLDS FOR TISSUE
ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS
Biologic ECM scaffolds are typically allogeneic or xenogeneic in origin and are derived
from a variety of tissues and organs, including but not limited to the following: pericardium
[29], fascia lata [30], dermis [31], small intestine [32, 33], and urinary bladder [32, 33]. ECM
scaffolds have been used as for the reconstruction of numerous tissue types in both preclinical
animal studies and in human clinical applications [32]. Further, acellular ECM scaffolds have
also been evaluated for their ability to maintain cell phenotype in vitro [28, 34-37]. Compared to
the use of individual components of ECM, such as type-1 collagen or laminin, studies have
shown that intact ECM provides a more favorable substrate for the growth and differentiation of
various cell types [28, 34, 38-40]. Squamous epithelial, fibroblastic (Swiss 3T3), glandular
epithelial (adenocarcinoma), and smooth muscle-like (urinary bladder) cells cultured on SIS-
ECM maintained superior expression of tissue-specific phenotype compared to those same cells
cultured on plastic, Vitrogen, or Matrigel [39]. In a study that utilized human islets, SIS
enhanced the functions of the islets in vitro compared to islets cultured on standard islet
substrates [40]. Lin et. al., recently compared hepatocytes cultured on LECM to the well
characterized hepatocyte culture models, double gel (“sandwich”) cultures and adsorbed type-1
collagen [28]. Hepatocytes survived up to 45 days on LECM and several liver-specific functions
such as albumin synthesis, urea production, and P-450 IA1 activity were significantly greater
compared to the growth and metabolism of cells cultured on collagen.
Our laboratory recently showed the origin or anatomic location from which the ECM
scaffold is derived can affect cell phenotype after only 24 hours [34]. Hepatic sinusoidal
endothelial cells (SEC) maintained their differentiated state the longest when cultured on ECM
8derived from the liver compared to ECM derived from either the urinary bladder (UBM-ECM) or
the small intestine (SIS-ECM). The SEC maintained fenestrations and expression of SE-1, a
marker specific to differentiated hepatic SEC, longer than SEC cultured on UBM-ECM or SIS-
ECM. The results of the study suggested that the liver-derived ECM provides a unique set of
tissue-specific signals that contribute to the maintenance of a site-specific, fenestrated phenotype
for SEC [34].
2.2 COMPOSITION OF EXTRACELLULAR MATRIX SCAFFOLDS
The ECM consists of a complex mixture of structural and functional proteins that provide
signals for cell growth, migration, proliferation, and differentiation. ECM is tissue and species-
specific and reflects the structural and functional requirements of the tissue or organ [41-43].
ECM scaffolds are produced by subjecting the tissue of interest to a series of chemical,
enzymatic, and/or mechanical treatments that remove the cellular components of the tissue,
leaving the ECM framework intact. The ECM scaffolds were prepared using methods that
preserved as much of the native composition and ultrastructure as well as the inherent structural
and functional proteins of the liver, which may explain the retained bioactivity [44, 45].
Since the ECM composition of tissues and organs vary throughout the body, the resulting
ECM biologic scaffolds also vary in composition. ECM scaffolds have been shown to be
composed of type I collagen with minor amounts of collagen types III, IV, V, VI and VII [44,
46]. ECM scaffolds have also been shown to retain a variety of glycosaminoglycans including
heparin, heparan sulfate, chondroitin sulfate A&B, and hyaluronic acid [47], and adhesion
9molecules such as fibronectin and laminin [44 , 47]. ECM scaffolds have been shown to retain
transforming growth factor (TGF-β) [39, 48], b-FGF [39, 49], vascular endothelial growth factor
(VEGF) [49], epidermal growth factor (EGF) and hepatocyte growth factor (HGF) (unpublished
data from Badylak Laboratory). Several of these growth factors have been shown to retain
bioactivity even after terminal sterilization and long-term storage [48, 49]. Differential
proteomics profiling of LECM confirmed the presence of the ECM proteins listed above
(unpublished data from collaboration with University of New South Wales Proteomics Facility,
Sydney, AU).
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3.0 MAINTAINENCE OF HEPATOCYTE-SPECIFIC FUNCTIONS IN VITRO
Complex inter-relations of cellular and non-cellular elements in the liver modulate
hepatoycte functions. The maintenance of hepatocyte phenotype is dependent on
microenvironmental signals such as paracrine interactions (cell-cell), physical-chemical factors
(i.e. oxygen tension, metabolites), mechanical stimuli (blood flow), and cell-extracellular matrix
interactions [41, 50-54]. Strategies commonly utilized to maintain long-term hepatocyte
functions in vitro include: (1) using hormonally defined media containing soluble factors; (2)
restoring cell-cell contacts by culturing PHH with other cells (either nonparenchymal liver cells
or nonhepatic cells); and (3) reestablishing cell-ECM contacts by culturing PHH with individual
ECM components or complex ECM substrata. A brief discussion of the effects of cell-cell
contacts and cell-ECM contacts upon maintainence of hepatocyte-specific functions is discussed
below.
3.1 CO-CULTURE WITH NON-PARENCHYMAL CELLS
Hepatocytes are the parenchymal cells of the liver and account for approximately 80% of
all liver cells [1, 2]. Hepatocytes perform most of the functions of the liver and work in concert
with a number of other cell types to perform the functions essential for survival of the individual.
The non-parenchymal cells (NPC) of the liver include: sinusoidal endothelial cells, Kupffer cells
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and stellate cells. Cocultivation of PHH with other cells types can maintain liver-specific
functions for several weeks in vitro [55]. Liver-derived NPCs [56-61] as well as non-hepatic
endothelial cells [60], epithelial cells, [62] and fibroblasts [60, 63, 64] have been cocultured
with hepatocytes to maintain hepatocyte morphology and a variety of synthetic, metabolic, and
detoxification functions of the liver. Bhatia et al, have provided an extensive summary of studies
used to preserve hepatoycte-specific functions in vitro through coculture with other cells [55].
3.2 CULTURE ON EXTRACELLULAR MATRIX SUBSTRATES
Individual ECM components or combinations of desired ECM components have been used as
substrates for hepatoycte culture systems for several decades [35, 65, 66]. While cell culture
substrates composed of individual ECM proteins such as type-1 collagen, laminin and
fibronectin have facilitated primary rat hepatocyte attachment and maintainence of a few liver-
specific functions and established hepatocyte polarity and morphology for short periods of
culture, these systems are far from physiologically relevant [67-70]. The lack of an intact ECM
that is composed of multiple ECM proteins specific to the native liver, affects cell-cell
interaction, cell-ECM interaction, physical-chemical influences, and mechanical stimuli. As a
result, the cells in culture eventually lose their functional cell phenotype [17].
Conventional culture models for hepatocytes include the use of type-I collagen and
MatrigelTM (MG) [71]. The sandwich configuration, where hepatocytes are cultured between
two layers of either type-I collagen or MG, is a commonly used hepatocyte culture model [26,
66, 72, 73]. Sandwich culture of rat hepatocytes maintains hepatoycte polarity and morphology
better than hepatocytes cultured on a single layer of type-I collagen or MG [35, 69, 74]. Further,
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hepatocyte-specific functions, such as cytochrome-P450 (CYP450) activity and responsiveness
[26, 66, 75, 76], albumin secretion [73], and urea synthesis, are enhanced when the sandwich
culture model is used.
Several investigators have cultured primary human hepatocytes (PHH) on type-1 collagen
with MG overlay [15, 26, 77]. The sandwich configuration facilitates maintenance and induction
of xenobiotic metabolizing enzymes, particularly the phenobarbital-mediated responsiveness of
cytochrome P450 2B6 [26]. Page et al recently showed that MG overlay enhanced PHH mRNA
expression levels for differentiated hepatocyte genes such as the cytochrome P450s, liver-
specific markers such as albumin, transferrin, and connexin 32 [78].
The use of complex ECM substrates derived from mammalian tissues for hepatocyte
culture began more than two decades ago. Early culture models utilized ECM substrates derived
from either rat liver [27, 37] or the Engelbreth-House sarcoma mouse tumor, which is called
Matrigel [71]. Rat hepatocytes cultured on type-1 collagen show less cell attachment and
survival compared to rat hepatocytes cultured upon a biomatrix derived from solubilized rat liver
[27].
More recently, ECM substrates derived from porcine, bovine, or human liver have been
used to improve hepatocyte survival, polarity and liver-specific functions in vitro (Table 1) [28,
35]. Lin et. al. compared rat hepatocytes cultured on ECM biologic scaffolds derived from
porcine liver (PLECM) to well characterized hepatocyte culture models (type-1 collagen
sandwich configuration or a single layer of type-1 collagen)[28]. Hepatocytes survived up to 45
days on a sheet form of PLECM and several liver-specific functions such as albumin synthesis,
urea production, and P-450 IA1 activity were markedly enhanced compared to the growth and
metabolism of cells cultured on a single layer of type-1 collagen.
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Zeisburg et al isolated liver-derived basement membrane matrix (LBLM) from human or
bovine liver, and used the substrate for culture of human hepatocytes [35]. Human hepatocytes
adhered more efficiently to LBLM and expressed lower levels of vimentin and cytokeratin-18,
which are markers of hepatocyte dedifferentiation, compared to hepatocytes cultured on MG or
type-1 collagen. However, maintainence of liver-specific functions in vitro was not reported
[35].
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Table 1. ECM Substrates Derived from Mammalian Tissues for Hepatocyte
Culture
Substrate Derived
From
ECM Composition
Biomatrix
Reid et al, 1980 Rat liver
Type-I collagen Type-111 collagen
Fibronectin
Matrigel
Kleinman et al, 1982
Engelbreth-
Holm-swarm
mouse sarcoma
tumor
Laminin
Type IV collagen
Entactin
Heparin sulfate proteoglycan
Chondroiton sulfate proteoglycan
ECM-bound growth factors
Basement Membrane
Matrix
Zeisberg et al, 2006
Bovine or
human liver
Type-IV collagen
Laminin
Entactin
Heparin sulfate proteoglycan
ECM Sheet Form
Lin et al, 2004 Porcine liver
Type-I collagen Type-VI collagen
Type-III collagen Type-IV collagen
Type XI collagen Type-XIX collagen
Heparin Sulfate Proteoglycan
Laminin Biglycan Tenascin
Fibronectin
ECM-bound growth factors
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4.0 MOTIVATION AND SPECIFIC AIMS OF THE PRESENT STUDY
The ability of the liver to regenerate is an important survival mechanism of the body. Up
to 75% of the liver mass can be surgically removed or destroyed by disease or chemical insult
before it ceases to function [79-81]. To restore the loss of tissue, the remaining liver cells regrow
to within 10% of the original mass by compensatory hyperplasia to form a functional tissue
replacement. However, when hepatocytes are isolated from their highly specialized
microenvironment in vivo, they are unable to proliferate in vitro. In addition to losing their
ability to proliferate in vitro, hepatocytes quickly lose their liver-specific functions without cell-
cell [55] or cell-ECM contacts [35, 82, 83]. Therapies to treat liver disease, including BAL
devices and tissue engineered constructs, have had limited clinical success because of the
inability to maintain the liver-specific functions of a large mass of isolated human hepatocytes.
The field of tissue engineering and regenerative medicine strives to restore liver function
by recreating the liver ex vivo and subsequently implanting the tissue-engineered construct, or to
provide a bridge to liver transplantation, utilizing a combination of cells and bioreactors to
perform the function of the liver ex vivo. The identification of a biologic scaffold that could
maintain a functional hepatocyte differentiation profile would represent an advancement toward
therapies to treat liver disease.
Studies have also shown that liver-specific functions can be maintained in vitro for several
weeks when hepatocytes are cultured on complex ECM substrata (MG, biomatrix, LBLM) or
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between two layers of MG/type-1 collagen [27, 28, 84]. While the results of these studies are
encouraging, the studies have utilized either porcine or rat hepatocytes.
Hepatoycte functions, such as drug metabolism, vary between species [85, 86] and the use
of a patient’s own cells would preclude the use of long-term immunosuppression. Only a few
studies have examined the effects of extracellular matrix substrates on maintainence of primary
human hepatocyte-specific functions [15, 26, 66, 75, 86, 87].
The overall goal of this project is to determine the ability of naturally-derived liver
extracellular matrix (LECM) to support primary human hepatocyte-specific functions in vitro.
The project is predicated upon the hypothesis that the scaffold or substrate upon which PHH are
seeded is a critical determinant of cell phenotype and function.
Bioscaffolds composed of LECM will be used as a substrate for hepatocyte growth and the
following variables will be evaluated for their ability to maintain hepatocyte phenotype in vitro:
(1) the source (i.e. species) of LECM scaffolds, and (2) the LECM geometrical configuration.
Based on the need to develop substrates that support primary human hepatocyte-specific
functions in vitro, the specific aims of the present study were the following:
1. To compare the effect of liver-derived ECM scaffolds derived from two different
species, human and porcine, on human hepatocyte-specific functions. The interaction of
hepatocytes with the ECM [88, 89] is essential for the maintainence of hepatocyte-specific
functions. While porcine liver is a readily available source for LECM, ECM from human liver
(HLECM) may support superior human hepatocyte function since ECM properties are tissue-
and species-specific [3, 43].
The specific aim was based on the hypothesis that PHH cultured with HLECM will have
enhanced liver-specific functions, compared to PHH cultured with PLECM, Matrigel or type-1
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collagen. The latter two are routinely used for hepatocyte culture, so they were also used in this
study for comparison. The mRNA levels of connexin 32, albumin, CYP1A1, CYP1A2, and
CYP3A4 were measured. Albumin secretion and cytochrome P450 1A1/1A2 and 3A4 activity
were used as indicators of hepatocyte functionality.
2. To determine the effect of porcine-derived ECM sandwich configuration upon
maintainence of hepatocyte-specific functions. Previous studies have shown that hepatocyte
polarity and liver-specific functions, such as albumin production, are stabilized in vitro for
longer periods of time when hepatocytes are cultured between two layers of a gel [74, 82, 90,
91].
The specific aim was based on the hypothesis that the primary human hepatocytes
cultured between two layers of PLECM will maintain hepatocyte-specific functions better than
primary human hepatocytes cultured on type-1 collagen alone or between two layers of Matrigel,
since PLECM composition is more similar to the native liver ECM composition compared to
Matrigel or type-1 collagen. The mRNA levels of connexin 32, albumin, bile salt export pump
(BSEP), and sodium taurocholate co transporting polypeptide (NTCP) were measured.
Hepatocyte functionality was assessed by albumin secretion, hepatic transport activity, and
ammonia metabolism.
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5.0 SPECIFIC AIM 1: THE EFFECT OF SPECIES-SPECIFIC ECM SCAFFOLDS
ON HEPATOYTE- FUNCTIONS IN VITRO
Previous studies have shown that intact ECM derived from mammalian organs provides a
more favorable substrate for the growth and differentiation of various cell types compared to the
use of individual components of ECM, such as type-1 collagen or fibronectin [28, 34, 36, 38-40].
Further, Sellaro et al showed that ECM scaffolds are tissue-specific [34] by culturing rat
sinusoidal endothelial cells (SEC), which are a highly specialized endothelial cell population
derived from the liver, on ECM derived from small intestine, urinary bladder, and liver. The SEC
maintained their phenotype the longest on ECM scaffolds derived from the liver.
Since Sellaro et al demonstrated that ECM retain their tissue-specificity, the next logical
question would examine if ECM scaffolds retain their species-specificity. Would ECM derived
from human liver support human hepatocyte functions better than ECM derived from porcine
liver since ECM are tissue- and species-specific [3, 43].
To address Specific Aim 1, PHH were cultured on type-1 collagen alone, or cultured on
type-1 collagen with either Matrigel, HLECM or PLECM overlay. The mRNA levels of
connexin 32, albumin, CYP1A1, CYP1A2, and CYP3A4 were measured. Albumin secretion
and cytochrome P450 inducibility and activity (CYP1A1/1A2 and CYP3A4) were used as
indicators of hepatocyte functionality.
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5.1 METHODS
5.1.1 Reagents
Pepsin, sodium hydroxide, glycerol, dibasic sodium phosphate, monobasic sodium
phosphate, dexamethasome, β-napthoflavone (β-NF), rifampicin (RIF), dimethylsulfoxide
(DMSO), ethoxyresorufin-O-deethylation (EROD), and EDTA were purchased from Sigma
Chemical Co. (St. Louis, MO). Trypsin was purchased from Gibco (Carlsbad, CA). Type-1
collagen was purchased from Becton Dickinson (Franklin Lakes, OR). Quant-iT PicoGreen
Assay was obtained from Invitrogen-Molecular Probes (Eugene, OR). Triton-X 100 and sodium
deoxycholic acid were purchased from Spectrum (Gardena, CA). Hepatocyte Maintainence
Media (HMM) was purchased from Cambrex (Baltimore, MD). Penicillin, streptomycin and
bovine calf serum were purchased from Gibco (Carlsbad, CA). Trizol reagent was purchased
from Invitrogen (Carlsbad, CA). Ethidium bromide was purchased from Sigma Chemical Co.
(St. Louis, MO). All quantitative real-time RT-PCR reagents were purchased from Applied
Biosystems (Foster City, CA). Cyclophilin albumin, CYP3A4, CYP1A1, and CYP1A2 were
synthesized by Applied Biosystems with assay identification numbers: cyclophilin
(Hs03045993_gH), Cx32 (Hs00702141_s1), albumin (Hs00910222_m1), CYP3A4
(Hs00604506_m1), CYP1A1 (Hs01054796_g1), and CYP1A2 (Hs01070374_m1).
5.1.2 Isolation and Preparation of Liver-derived Extracellular Matrix (LECM) Scaffolds
ECM scaffolds have been isolated from a variety of species, including the following:
porcine, canine, ovine, bovine, ratus, murine, and human. Mammalian tissue and organ sources
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for ECM scaffolds include but are not limited to the following: brain (unpublished data Badylak
Laboratory), lung, pancreas [92], tendon, trachea [93], adrenal [94], amnion [95], peripheral
nerve [96], skin [31], small intestine [97], urinary bladder [98, 99], stomach [100], heart [101],
pericardium [29], and liver [28]. Combinations of physical, chemical and enzymatic techniques
are used to decellularize tissues and organs. Because of the tissue- and species-specificity of
tissue and organs, decellularization protocols are tailored for a specific tissue or organ. For
instance, the decellularization protocol of small intestine [102] is very different than the
decellularization protocol for cardiac tissue [103]. Gilbert, Sellaro, and Badylak recently
published an extensive summary of decellularization protocols and techniques [104].
Isolation and Preparation of ECM. The methods used to isolate porcine liver ECM
(PLECM) have been previously described [28, 44, 104]. Livers were harvested from market
weight pigs (~110-130kg) immediately after euthanasia. The tissues were rinsed with tap water
and frozen until used. Each liver lobe was cut into 5 mm thick slices with a rotating blade and
subjected to three separate 30 minute washes in deionized water with mechanical agitation on an
orbital shaker. The sections were then gently massaged to aid in cell lysis and soaked in 0.02%
trypsin/0.05% EDTA at 37° C for one hour. The tissue was rinsed in deionized water and the
massaging was repeated followed by mechanical agitation of the liver sections in 3% Triton X-
100 for one hour. The rinsing and massaging process was repeated until all visible remnants of
cellular material were removed. The tissue sections were then mechanically agitated in 4%
sodium deoxycholic acid for one hour followed by rinsing in water a minimal of three times.
Tissues were immersed in a solution of 0.1% peracetic acid followed by three rinses in water or
phosphate buffered saline at pH 7.4 [105]. The resulting decellularized connective tissue matrix
was referred to as PLECM [28].
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Human liver tissue was obtained from donor livers that had not been used for
transplantation. The same protocol delineated above was followed for the decellularization of
human liver tissue, with the following modifications. After sectioning of the liver tissue into 5
mm thick slices, each tissue slice was transferred into individual mesh bags that were
subsequently sealed. The encasement of liver slices within mesh bags prevented tearing of the
tissue, since human liver tissue tore more easily than porcine liver tissue. The holes in the mesh
bag facilitated transfer of solutions to the tissues. Prior to placing the human liver tissue on the
mechanical orbital shakers for the first time, the human liver tissue was stored in deionized water
at 4° C for 72 hours. The deionized water was changed daily. A small amount (0.001 g per flask)
of sodium azide was added to the solution to prevent contamination. Tissues were immersed in a
solution of 0.1% peracetic acid followed by three rinses in water or phosphate buffered saline at
pH 7.4 [105]. Following decellularization, the resulting acellular connective tissue matrix was
referred to as HLECM (Figures 1A&B).
DAPI and hematoxylin and eosin staining were performed on random samples to assess
degree of decellularization of human and porcine liver tissues. Figure 2 shows the H&E and
DAPI staining for native human liver (Figures 2A&B) and decellularized human liver (Figures
2C&D).
5.1.3 Preparation of ECM Digests
The method used to prepare a digest of harvested ECM has been previously described
[99]. The protocol was adapted to produce a digest from porcine and human liver. A powdered
form of LECM was produced from sheets of LECM. The hydrated, sheet form of the disinfected
ECM was lyophilized overnight. Lyophilized sheets of LECM were cut into small pieces, and
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then placed in a rotary knife mill (Wiley Mill) to create a particulate form of the ECM. Particles
less than 250 micron were collected by sieve through a #60 mesh screen.
One gram of lyophilized LECM powder and 100 mg of pepsin (2000-3000 U/mg) were
mixed in 100 mL of 0.01 M HCl and stirred for ~72 hours at room temperature (25ºC). The final
viscous solution of digested LECM or pre-gel solution had a pH of approximately 3.0 - 4.0.
Inactivation of pepsin activity occurred when the pH was raised to 7.4.
5.1.4 Isolation and Culture of Primary Human Hepatocytes.
Hepatocytes were isolated from either donor livers that were not used for transplantation
or from areas of hepatic tissue that were not involved in tumor from tissue resections for cancer.
All human subject protocols were reviewed and approved by the University of Pittsburgh
Institutional Review Boards. Hepatocytes in this study were isolated from six human donors of
different age groups, genders and medical histories (Table 2). Significant amounts of steatosis
(fat) were not observed in any of the livers. Viability of the hepatocytes at the time of plating
was greater than 70%, as measured by trypan blue exclusion.
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Table 2. Donor Information for Human Hepatocyte Preparations For Specific Aim 1.
83%NANKResectionNDM37HH1332
Omeprozole,
Celebrex,
Glimpride,
Trazadone,
Effexor, Zetia,
Detrol, Actus,
Accupril
NK
None
None
Chemotherapy
Drug History
Intercranial
Hemorrhage
NA
Non-heart
beating donor
Intercranial
Bleed
NA
Cause of
Death
61
72
25
44
54
Age
F
M
F
F
M
Sexa
C
C
C
C
ND
Raceb
Organ Donor
Resection
Organ Donor
Organ Donor
Resection
Tissue
Resection or
Organ Donor
91%
HH1369
91%HH1367
70%HH1356
82%HH1344
73%HH1338
ViabilityDonor
HH#
ND, data not provided; NK, no known chronic drug treatment; NA, not applicable
aM, male; F, female; bC, Caucasion
PHH were isolated by a three-step collagenase perfusion of human liver [106] and plated
in 6-well plates precoated with adsorbed type-1 collagen at a seeding density of 1.5x106 cells per
well. HMM supplemented with 10-7 M dexamethasome, 10-7 M insulin, 100 U/mL penicillin,
100 µg/ml streptomycin and 10% bovine calf serum. After 4 hours of culture at 37° C, the media
was replaced with serum free HMM with the supplements listed above and changed every 24 hrs.
After 24 hrs of culture, unattached PHH were removed by gentle agitation and PHH were
overlaid with a solution of HMM containing either 0.222 mg/ml of MG, HLECM digest or
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PLECM digest (Figure 3). The HMM-ECM solutions formed a semi-solid layer over the cells.
Media was changed daily.
5.1.5 Light Microscopy of Primary Human Hepatocytes
PHH were maintained in HMM media for seven days under different extracellular matrix
(ECM) conditions. On day five, PHH cultured on type- 1 collagen alone, or on type-1 collagen
with either MG, HLECM, or PLECM overlay were imaged at 100x with a light microscope.
5.1.6 Measurement of DNA Content
Using a cell scraper, cells were harvested on ice in 150 µl cell harvest buffer containing:
dibasic sodium phosphate (11.5 g/L), monobasic sodium phosphate (2.6 g/L), EDTA (0.033 g/L),
and 20% glycerol. The cell lysates were produced by sonication and stored at –20° C. Total
DNA was quantified using the commercially available Quant-iT Picogreen dsDNA Kit according
to the manufacturer’s instructions. For each group, a minimum of two samples were used to
determine total DNA and each samples was measured in triplicate.
5.1.7 RNA Isolation and Quantitative real time RT-PCR Methods
Total RNA was isolated using Trizol Reagent as described by the manufacturer’s
instructions. RNA concentration was determined by spectrophotometer (µQuant Microplate
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Spectrophotometer, Biotek Instruments, Winooski, VT) at 260 nm. The purity of RNA was
determined by spectrophotometry at 280 nm and the integrity checked by agarose gel
electrophoresis stained with ethidium bromide. RNA was stored at −80° until further use.
mRNA expression levels of albumin, BSEP, and NTCP were determined using TaqMan
quantitative reverse-transcriptase polymerase chain (TaqMan QRT–PCR) assays. From each
group, 2 µg of total RNA was incubated with 5 U RQ DNase, 5 µL 10 x RQ buffer in a total
volume of 10 µL at 37°C for 30 min. The samples were then incubated with 1 µL RQ DNase
Stop Solution at 65°C for 10 min. The DNAse treated RNA was then incubated with 1 µL of
random hexamer primers (100 ng/ L) at 70°C for 5 min for cDNA synthesis. cDNA generation
continued with incubation at 37°C for 60 min with the following reagents: 1 µL dNTP (10
mmol/L of each), 5 µL MMLV 5x, and 1 µL MMLV RT for a total volume of 12 µL.
Cyclophilin, albumin, CYP1A1, CYP1A2, CYP3A4, and Cx32 specific primers and
probe were purchased as a pre-developed gene expression assay and used according to
manufacturer’s instructions.
TaqMan one-step RT–PCR assays were performed with 4 ng of each RNA sample in a
final reaction volume of 72 μL prepared from TaqMan one-step RT–PCR Master Mix Reagents
Kit. Assays were performed using an Applied Biosystems’ ABI Prism 7900HT sequence
detection system. An initial RT step occurred for 30 min at 48° and was subsequently followed
by heating to 95° for 10 min followed by 40 cycles of 95° for 15 s, 60° for 1 min.
5.1.8 Measurement of Albumin Secretion
Due to limited availability of cells, conditioned media was collected from donors
HH1356, HH1367, and HH1369 on days three, five, and seven, and stored at -20°C until
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analysis. PHH secretion of albumin was measured using a commercially available kit (Bethel
Laboratories, Texas). At least three samples were collected from each culture condition and each
sample was measured in triplicate. All data was normalized to total DNA content.
5.1.9 RIF-Induced CYP3A4 Activity
The concentration of 6β-hydroxytestosterone in the medium was measured by HPLC in five
independent PHH preparations (Table 2: HH1338-HH1369) as previously described [107], with
the following modifications. PHH were induced with 10 µM RIF for 72 hours. At day five,
culture media was changed and PHH were incubated with HMM containing 0.25 mmol/L
testosterone for 30 minutes at 37°C. From each group, 500 µL of medium were collected from
three samples and were diluted with an equal volume of methanol and centrifuged at 13,000
r.p.m. for five minutes. One hundred microliters of the conditioned media with methanol solution
was injected into a LiChristopher 100 RP-18 column (4.6 x 250 mm, 5 µm). 6-
hydroxytestosterone was eluted with a mobile phase of methanol/water (60:40, v/v) at a flow rate
of 1.2 ml/min and the eluents were monitored at 242 nm. The concentration of the 6-(OH) TE
metabolite was determined by comparing the peak areas in samples to a standard curve
containing a known amount of the metabolite. All data was normalized to total DNA content of
each sample.
5.1.10 β-NF-Induced CYP1A1/1A2 Activity
β-NF-induced CYP1A1/1A2 activity was measured in five independent PHH preparations
(Table 2: HH1338-HH1369) on day five using a method previously described [108]. Briefly,
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PHH were induced with 10 µM β-NF for 72 hours. On day five, PHH were challenged with 0.25
mmol/L EROD prepared in HMM. CYP1A1/1A2 activity is measured by EROD activity, which
is the conversion of EROD to resorufin. After 30 min of incubation with EROD at 37°C, 250
µL of media was collected from each well. EROD activity was measured by a fluorescent
spectrometer (LS-50b from Perkin-Elmer). For each group, media was collected from a
minimum of three samples and each sample was measured in triplicate. Resorufin formation was
measured by comparing the fluorescence to a standard curve of resorufin prepared in HMM. All
data was normalized to total DNA content of each sample.
5.1.11 Statistical Analysis.
All values were calculated as mean ± S.D. For statistical analysis, all data was
normalized to PHH cultured on type-1 collagen. A one-way analysis of variance with a post-hoc
Tukey’s multiple comparison procedure was performed. A p value of < 0.05 was considered
statistically significant and all calculations were performed using SAS software, version 9.1
(Cary, NC).
5.2 RESULTS
A summary of all techniques used to characterize hepatocyte phenotype is in Figure 4.
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5.2.1 Effect of ECM Overlay on Hepatocyte Morphology
The PHH attached to collagen-type 1 showed the typical morphological appearance of
PHH as viewed by light microscopy. PHH had polygonal shapes with one or more nuclei per
cell. PHH had similar morphologies regardless of the culture conditions (Figures 5A-C).
5.2.2 Effect of ECM Overlay on DNA Contents
Average DNA content of PHH varied between livers. PHH isolated from HH1332 had
the highest average DNA content of 3.65±0.14 µg (Figure 6A). PHH isolated from HH1338 had
an average DNA content of 1.68±0.24 µg (Figure 6B) and PHH isolated from HH1344 had an
average DNA content of 1.55±0.41 µg (Figure 6C). PHH isolated from HH1356 and HH1367
had an average DNA content of 2.85±0.31 µg (Figure 6D) and 1.11±0.28 µg (Figure 6E),
respectively. PHH isolated from HH1369 had an average DNA contents of 1.63±0.34 µg (Figure
6F).
Average DNA contents for PHH cultured on type-1 collagen alone was 1.6±0.67 µg, and
the DNA content for PHH cultured on type-1 collagen with either MG, HLECM, or PLECM was
1.93±0.51 µg, 2.09±0.93 µg, and 2.11±0.79 µg, respectively (Figure 7). The DNA content of
PHH were similar, regardless if an overlay was used.
When data from each group was averaged and normalized to DNA content of PHH
cultured on type-1 collagen, no statistical differences were measured between the groups (Figure
8).
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5.2.3 Effect of ECM Overlay on Cx32 mRNA Expression
Individual donor Cx32 mRNA expression values are reported in Figure 9. Due to
technical difficulties with RNA isolation from HH1367, Cx32 mRNA expression data was not
graphed. For HH1338, HH1344, and HH1356, PHH cultured with ECM OL had higher Cx32
mRNA expression levels than PHH cultured on type-1 collagen only. For HH1369, PHH
cultured on type-1 collagen alone had the highest Cx32 mRNA expression levels.
Data from each culture condition was averaged and normalized to data from PHH
cultured on type-1 collagen only. PHH had similar Cx32 mRNA expression levels, regardless of
the culture condition (Figure 10).
5.2.4 Effect of ECM Overlay on Alb mRNA Expression
Albumin mRNA expression was measured in PHH isolated from donors HH1356,
HH1367, and HH1369 because albumin secretion was measured in PHH isolated from these
livers. Figure 11 shows the albumin mRNA expression from each liver. For HH1344, PHH
cultured with MG overlay had the highest albumin mRNA expression levels (Figure 11A). For
HH1356, PHH cultured with HLECM overlay had the highest albumin mRNA expression levels
(Figure 11B) while in HH1369, PHH cultured on type-1 collagen had the highest albumin
mRNA expression levels (Figure 11C).
Data from each culture condition was averaged and normalized to PHH cultured on type-
1 collagen only. PHH had similar albumin mRNA expression levels, regardless of the culture
condition (Figure 12).
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5.2.5 Effect of ECM Overlay on Albumin Secretion
Albumin secretion was measured on days three, five and seven in the following donor
cases: HH1356, HH1367, and HH1369.
Figure 13 shows the albumin concentrations in conditioned media of PHH isolated from
each liver and cultured on type-1 collagen alone (Figure 13A), or type-1 collagen with MG
(Figure 13B), HLECM gel (Figure 13C), or PLECM gel overlay (Figure 13D). In HH1356,
albumin secretion levels were comparable regardless of day or presence of ECM overlay. In
HH1367, PHH cultured with MG overlay had higher levels of albumin secretion than PHH
cultured on type-1 collagen on all days. PHH cultured with HLECM overlay had comparable
levels of albumin secretion to PHH cultured with type-1 collagen alone at day three and seven.
PHH cultured with PLECM overlay had higher levels of albumin secretion on day three and
seven compared to PHH cultured on type-1 collagen alone. In HH1369, PHH cultured with MG
overlay had higher levels of albumin secretion on all days compared to PHH cultured on type-1
collagen alone. PHH cultured with HLECM overlay had higher levels of albumin secretion on
day seven compared to PHH cultured on type-1 collagen alone. PHH cultured with PLECM
overlay had higher levels of albumin secretion on day five and seven compared to PHH cultured
on type-1 collagen only.
Albumin secretion data from each culture condition was averaged and normalized to the
albumin secretion data from PHH cultured on type-1 collagen at day three. PHH had comparable
levels of albumin secretion of days three, five and seven regardless of culture condition (Figure
14).
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Albumin secretion was calculated as the average amount of secretion per day (Figure 15)
Due to large variability in albumin secretion values from donor to donor, average albumin
secretion values were not different between the groups (Figure 15).
5.2.6 Effect of ECM Overlay on CYP3A4 mRNA Expression
Non-RIF induced and RIF-induced CYP3A4 mRNA expression levels of each donor are
shown in Figure 16. Due to a technical difficulty with the RNA of HH1367, only mRNA values
for PHH cultured with either HLECM or PLECM overlay were shown. In all cases, RIF
induction of PHH increased the CYP3A4 mRNA expression levels compared to the controls
(non-RIF induced).
When the CYP3A4 mRNA expression data from each culture condition was averaged
and normalized to the data from PHH cultured on type-1 collagen only, no differences in
CYP3A4 expression levels were measured (Figure 17).
5.2.7 Effect of ECM Overlay on RIF-Induced CYP3A4 Activity
RIF is an inducer of CYP3A4 activity. CYP3A4 metabolizes TE and a metabolite is
6β(OH)-TE. Each experiment had RIF-induced PHH and non-RIF induced PHH (controls). RIF-
induced PHH were incubated with RIF for 72 hours prior to addition of TE. RIF-induced PHH
had increased levels of 6β(OH)-TE formation compared to controls (non-RIF induced PHH).
PHH isolated from HH1332 were cultured on type-1 collagen with either a MG or
HLECM overlay. PHH cultured with MG overlay had an 8.0 ±0.4-fold increase in the formation
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rate of 6β(OH)-TE compared to control. PHH cultured with HLECM overlay had a 14.5±0.7-fold
increase in the formation rate of 6β(OH)-TE compared to control (Figure 18A).
PHH isolated from HH1338 were cultured on either type-1 collagen, or type-1 collagen
with either MG or HLECM overlay. RIF induced PHH cultured on type-1 collagen had a
9.1±5.8-fold increase in formation of 6β(OH)-TE compared to control. PHH cultured with MG
overlay had an 8.5±1.1-fold increase in the formation rate of 6β(OH)-TE compared to control.
PHH cultured with HLECM overlay had a 24.3±7.1-fold increase in the formation rate of
6β(OH)-TE compared to control (Figure 18B).
PHH isolated from HH1344, HH1356, and HH1367 were cultured on either type-1
collagen, or type-1 collagen with either a MG, HLECM or PLECM overlay. For HH1344, RIF
induced PHH cultured on type-1 collagen produced 4.3±1.3-fold higher 6β(OH)-TE formation
rate compared to control. PHH cultured with MG overlay increased 6β(OH)-TE formation by
6.9±1.3-fold compared to control. PHH cultured with HLECM overlay had a 5.2±2.5-fold
increase in the formation rate of 6β(OH)-TE compared to control. PHH cultured with PLECM
had a 3.4±0.6-fold increase in the formation rate of 6β(OH)-TE compared to control (Figure
18C).
For HH1356, RIF induced PHH cultured on type-1 collagen only had a 3.1±0.3-fold
higher 6β(OH)-TE formation rate compared to control. PHH cultured with MG overlay had an
34.3±4.3-fold increase in the formation rate of 6β(OH)-TE compared to control. PHH cultured
with HLECM overlay had a 35.3±1.4-fold increase in the formation rate of 6β(OH)-TE
compared to control. PHH cultured with PLECM had a 40.8±0.9-fold increase in the formation
rate of 6β(OH)-TE compared to control (Figure 18D).
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For HH1367, PHH in all culture conditions had comparable levels 6β(OH)-TE formation
rate. RIF induced PHH cultured on type-1 collagen had a 9.6±1.9-fold higher 6β(OH)-TE
formation rate compared to control. PHH cultured with MG overlay had an 10.9±3.7-fold
increase in the formation rate of 6β(OH)-TE compared to control. PHH cultured with HLECM
overlay had a 8.8±2.0-fold increase in the formation rate of 6β(OH)-TE compared to control
(Figure ). PHH cultured with PLECM had a 11.1±3.0-fold increase in the formation rate of
6β(OH)-TE compared to control (Figure 18E).
For HH1369, PHH in all culture conditions had comparable levels 6β(OH)-TE formation
rate. RIF induced PHH cultured on type-1 collagen had a 2.0±0.3-fold higher 6β(OH)-TE
formation rate compared to control. PHH cultured with MG overlay had an 2.3±0.6-fold
increase in the formation rate of 6β(OH)-TE compared to control. PHH cultured with HLECM
overlay had a 2.9±0.1-fold increase in the formation rate of 6β(OH)-TE compared to control.
PHH cultured with PLECM had a 3.8±2.7-fold increase in the formation rate of 6β(OH)-TE
compared to control (Fig 18F).
6β(OH)-TE formation data from each culture condition was averaged and normalized to
the 6β(OH)-TE concentrations of RIF-induced PHH cultured on type-1 collagen. Due to large
variability in 6β(OH)-TE formation in RIF-induced PHH from donor to donor, 6β(OH)-TE
formation values were not different between the groups (Figure 19).
5.2.8 Effect of ECM Overlay on CYP1A1 mRNA Expression
CYP1A1 mRNA expression values are shown in Figure 20. In all cases, β-NF induction
of PHH increased the CYP1A1 mRNA expression levels compared to the controls (non- β-NF
induced).
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For HH1338 and HH1356, PHH had similar levels of CYP1A1 mRNA expression
(Figures 20 B & D). In HH1344, PHH cultured on type-1 collagen alone had the highest
CYP1A1 mRNA expression (Figure 20C). For HH1367, there were technical difficulties with
MG control RNA so the control mRNA expression was not plotted. For HH1367, PHH cultured
with either MG or PLECM overlay had the highest CYP1A1 mRNA expression (Figure 20E).
For HH1369, PHH cultured with PLECM overlay had the highest levels of CYP1A1 mRNA
expression (Figure 20F).
When CYP1A1 mRNA data from each culture condition was averaged and normalized to
the data of PHH cultured on type-1 collagen, PHH had similar CYP1A1 mRNA expression
levels (Figure 21).
5.2.9 Effect of ECM Overlay on CYP1A2 mRNA Expression
Individual donor CYP1A2 mRNA expression values are shown in Figures 22 A-F. In all
cases, β-NF induction of PHH increased the CYP1A2 mRNA expression levels compared to the
controls (non- β-NF induced). In HH1332, HH1338, and HH1367, PHH cultured with HLECM
overlay had the highest CYP1A2 mRNA expression levels (Figures 22A-B, E). In HH1344, PHH
cultured on type-1 collagen alone had the highest CYP1A2 mRNA expression levels (Figure
22C). For HH1356, PHH cultured with PLECM overlay had the highest CYP1A2 mRNA
expression levels (Figure 22D) while in HH1369, PHH cultured with MG overlay had the
highest CYP1A2 mRNA expression levels (Figure 22E).
When CYP1A2 mRNA data from each culture condition was averaged and normalized to
the data of PHH cultured on type-1 collagen, PHH had similar CYP1A2 mRNA expression
levels (Figure 23).
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5.2.10 Effect of ECM Overlay on β-NF-Induced CYP1A1/1A2 Activity
β-NF upregulates CYP1A1/1A2 activity. CYP1A1/1A2 metabolizes EROD and a
metabolite is resorufin. Each experiment had β-NF-induced PHH and controls (non- β-NF
induced PHH). β-NF-mediated CYP1A1/1A2 activity increased in PHH for all donors compared
to controls (Figure 24).
PHH isolated from HH1332 were cultured on type-1 collagen with either a MG or
HLECM overlay. β-NF-induced PHH cultured with either MG or HLECM overlay had
comparable levels of fold increase resorufin formation over control, 15.3±0.4-and 15.7±0.4-fold
increase, respectively (Figure 24A).
PHH isolated from HH1338 were cultured on either type-1 collagen, or type-1 collagen
with either MG or HLECM overlay. β-NF induced PHH cultured on type-1 collagen produced
7.5±0.8-fold higher resorufin formation compared to control. PHH cultured with MG overlay
had a 3.8±0.1-fold increase in the resorufin formation compared to control, while PHH cultured
with HLECM overlay had a 4.9±0.4-fold increase in the resorufin formation (Figure 24B).
PHH isolated from HH1344, HH1356, HH1367, and HH1369 were cultured on either
type-1 collagen, or type-1 collagen with either a MG, HLECM or PLECM overlay. For
HH1344, β-NF induced PHH cultured on type-1 collagen alone produced 8.67±0.7-fold higher
resorufin formation compared to control. PHH cultured with MG overlay had a 6.8±0.7-fold
increase in the resorufin formation compared to control. PHH cultured with HLECM overlay had
an 11.4±2.4-fold increase in the resorufin formation compared to control. PHH cultured with
PLECM had a 8.1±0.1-fold increase in the resorufin formation compared to control (Figure
24C). For HH1356, β-NF induced PHH cultured on type-1 collagen had a 42.2±9.7-fold increase
in resorufin formation compared to control. PHH cultured with MG overlay had a 56.2±4.5-fold
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increase in resorufin formation compared to control. PHH cultured with HLECM overlay had a
41.8±2.7-fold increase in resorufin formation compared to control. PHH cultured with PLECM
had a 41.2±0.5-fold increase in resorufin formation compared to control (Figure 24D). For
HH1367, β-NF induced PHH cultured on type-1 collagen had a 4.1±0.7-fold increase in resorufin
formation compared to control. PHH cultured with MG overlay had a 10.9±1.5-fold increase in
resorufin formation compared to control. PHH cultured with HLECM overlay had a 15.1±0.5-
fold increase in the resorufin formation compared to control. PHH cultured with PLECM had a
8.9±0.2-fold increase in resorufin formation compared to control (Figure 24E). For HH1369, β-
NF induced PHH cultured on type-1 collagen had a 15.1±0.7-fold increase in resorufin formation
compared to control. PHH cultured with MG overlay had a 15.0±2.3-fold increase in resorufin
formation compared to control. PHH cultured with HLECM overlay had a 13.0±1.6-fold increase
in the resorufin formation compared to control. PHH cultured with PLECM overlay had a
12.6±2.0-fold increase in resorufin formation compared to control (Figure 24F).
When the resorufin formation of β-NF-induced PHH from group was averaged and
normalized to the resorufin formations of β-NF-induced PHH cultured on type-1 collagen, no
differences were measured (Figure 25).
5.3 DISCUSSION
PHH in all culture configurations had robust RIF-induced CYP3A4 activity and robust β-
NF induced CYP1A1/1A2 activity. However, a pronounced ECM-dependent induction response
was not observed in PHH treated with RIF or β-NF: ECM overlays did not correlate to higher
levels of induced CYP3A4 or CYP1A1/1A2 activity. Other studies have also shown that the
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presence of a complex ECM substrate or overlay does not affect the inducibility of PHH. Silva et
al. cultured PHH on either type-1 collagen or MG [75] and showed that PHH had similar levels
of RIF-induced CYP3A4 activity, regardless of the substrate. Hamilton et al. showed that MG
overlays had no significant effect of RIF-induced CYP3A4 and β-NF-induced CYP1A1/1A2
activity [66].
In contrast, Gross-Steinmeyer et al. demonstrated a 2.1 fold increase in phenobarbital-
mediated CYP1A1/1A2 activity in PHH cultured with a MG overlay compared to PHH cultured
on type-1 collagen. Phenobarbital-mediated CYP2B6 activity had a 1.8 fold increase in PHH
cultured with MG overlay compared to PHH cultured on type-1 collagen.
Previous studies have shown that the culture of rat hepatocytes on type-1 collagen
precipitates the rapid decline of liver-specific functions [28, 73]. However, when rat hepatocytes
were cultured in between two layers of type-1 collagen or ECM such as MG, albumin secretion
increased as compared to hepatocytes on type-1 collagen only [28, 73]. Extrapolation of
experimental data from one species to another is difficult because of the species-specificity of
hepatocytes [109, 110]. In the present study, albumin secretion does not increase significantly in
PHH that are cultured with an ECM overlay. Jasmund et. al. compared albumin secretion of
PHH cultured on type-1 collagen alone or on type-1 collagen with a biomatrix overlay (derived
from porcine liver) overlay. PHH secreted similar levels of albumin, regardless of the presence
of a biomatrix overlay, which supports the findings from the present study [86].
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5.4 CONCLUSIONS
This study was one of the first set of experiments that evaluated the ability of ECM
derived from porcine and human liver to maintain PHH functions in vitro. In this study, PHH
has similar functional profiles regardless of the presence of an ECM overlay. The lack of
differences in several functional assays, including albumin secretion and CYP450 inducibility,
suggest that PHH cultured with PLECM overlay will perform as well as PHH cultured with
HLECM overlay. Regarding production of ECM scaffolds for clinical applications, these
findings are attractive because porcine liver tissues are readily available compared to human
liver tissues.
5.5 LIMITATIONS
In this study, albumin secretion and RIF- and β-NF-induced CYP450 activity were used
to assess hepatocyte functionality. Other measurements of hepatocyte functionality, such as urea
synthesis and hepatic transport activity, would be useful.
Hepatocyte functionality was measured for only seven days. Tissue engineered liver
constructs may need to maintain the functionality and viability of a large mass of isolated PHH
for longer periods of time, even up to six weeks. Future studies should measure hepatoycte
functionality for longer periods.
The biochemical composition of HLECM and PLECM digests are unknown. A biochemical
profile detailing the structural and functional proteins present in HLECM and PLECM digests
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would be useful, and should include the types of collagen, glycosaminoglycans, and growth
factors present.
Due to large variability from donor to donor, no statistical significances were measured in
any of the hepatocyte functionality assays. However, trends in some of the donor cases indicated
increased hepatocyte functionality of PHH cultured with PLECM and HLECM overlays
compared to PHH cultured on type-1 collagen. If more patient samples were added to the study,
the data may become statistically significant. However, the availability of human liver tissues for
PHH isolation is limited and very costly.
Figure 1. Macroscopic image of the sheet form of (A) HLECM and (B) SEM of
HLECM (2500x).
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Figure 2. Native human liver and decellularized human liver ECM (100x). (A)
Hematoxylin and eosin staining of native human liver and (B) DAPI staining of native
human liver. (C) Hematoxylin and eosin staining and (D) DAPI staining of HLECM. Note
the lack of intact nuclei after decellularization.
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Hepatocytes
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Figure 3. Schematic of experiment. PHH are plated on type-1 collagen. After 24
hours, either a MG, HLECM, or PLECM overlay was added.
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Figure 4. Schematic of techniques and assays used to profile hepatocyte phenotype.
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Figure 5. Primary human hepatocyte at day ten. Comparison of morphologic
appearance of PHH cultured on (A) type-1 collagen, or (B) type-1 collagen with MG
overlay, or (C) with HLECM overlay or (D) PLECM overlay (200x).
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Figure 6. DNA content of PHH derived from different livers. Values are expressed
as mean±SD. CT represents control (non-induced PHH), NF represents BNF-induced
PHH, and RIF represents RIF-induced PHH.
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Figure 7. Average DNA content of PHH cultured on type-1 collagen, or on type-1
collagen with either MG, HLECM, or PLECM overlay. Values represent mean±SD of five
livers.
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Figure 8. Effect of ECM overlay on DNA Content. Data was normalized to DNA
content of PHH cultured on type-1 collagen only. Values represent mean±SD of five livers.
46
HH1344
COL MG OL HLECM OL PLECM OL
C
x3
2
m
R
N
A
Ex
pr
es
si
on
0.0
0.1
0.2
0.3
0.4
HH1356
COL MG OL HLECM OL PLECM OL
C
x3
2
m
R
N
A
E
xp
re
ss
io
n
0.0
0.1
0.2
0.3
0.4
HH1338
COL MG OL HLECM OL
C
x3
2
m
R
N
A
E
xp
re
ss
io
n
0.0
0.1
0.2
0.3
0.4
A B
C
HH1369
COL MG OL HLECM OL PLECM OL
C
x3
2
m
R
N
A
Ex
pr
es
si
on
0.0
0.2
0.4
0.6
0.8
1.0
D
Figure 9. Effect of ECM overlay on Cx32 mRNA expression at day five. PHH were
cultured on type-1 collagen or type-1 collagen with either MG, HLECM, or PLECM
overlay. All mRNA values are normalized to cyclophilin expression.
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Figure 10. Effect of ECM overlay on average Cx32 mRNA expression at day five.
Average Cx32 mRNA expression of PHH cultured on type-1 collagen only or type-1
collagen with either MG, HLECM, or PLECM overlay. Data normalized to Cx32 mRNA
expression of PHH cultured on type-1 collagen only. Values represent mean±SD of four
livers.
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Figure 11. Effect of ECM overlay on albumin mRNA expression of PHH derived
from (A) HH1356, (B) HH1367, and (C) HH1369 at day five. All mRNA values are
normalized to cyclophilin expression.
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Figure 12. Effect of ECM overlay on average albumin mRNA expression. Average
albumin mRNA expression of PHH cultured on type-1 collagen only or type-1 collagen with
either MG, HLECM, or PLECM overlay at day five. All data was normalized to albumin
mRNA data from PHH cultured on type-1 collagen only. Values represent mean±SD of
three livers.
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Figure 13. Effect of ECM overlay on albumin secretion of PHH at days three, five,
and seven. PHH cultured on (A) type-1 collagen only, or on (B) type-1 collagen with MG,
(C) HLECM, or (D) PLECM overlay. Values represent mean±SD.
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Figure 14. Effect of ECM overlay on average albumin secretion of PHH. Average
albumin secretion at days three, five, and seven of PHH cultured on type-1 collagen only or
type-1 collagen with either MG, HLECM, or PLECM overlay. All data was normalized to
albumin secretion of PHH cultured on type-1 collagen only at day three. Values represent
mean±SD of three livers.
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Figure 15. Effect of ECM overlay on average albumin secretion per day of PHH.
Average albumin secretion per day of PHH cultured on type-1 collagen only or type-1
collagen with either a MG, HLECM, or PLECM overlay. Values represent mean±SD of
three livers.
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Figure 16. Effect of ECM overlay on CYP3A4 mRNA expression at day five. PHH
were cultured on type-1 collagen or type-1 collagen with either MG, HLECM, or PLECM
overlay. CT represents control (non-RIF induced PHH). Values represent mean±SD. All
data was normalized to cyclophilin expression.
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Figure 17. Effect of ECM overlay on average CYP3A4 mRNA expression at day
five. PHH were cultured on type-1 collagen or type-1 collagen with either MG, HLECM,
or PLECM overlay. Data normalized to CYP3A4 mRNA expression of PHH cultured on
type-1 collagen. All data was normalized to cyclophilin expression. Values represent
mean±SD. Values represent mean±SD of four livers.
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Figure 18. Effect of ECM overlay on CYP3A4 activity (6β(OH)-TE formation) at
day five. PHH were cultured on type-1 collagen only or type-1 collagen with either MG,
HLECM, or PLECM overlay. Values represent mean±SD. CT represents control (non-
induced PHH), NF represents BNF-induced PHH, and RIF represents RIF-induced PHH.
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Figure 19. Effect of ECM overlay on RIF-induced CYP3A4 activity of PHH at day
five. PHH were cultured on type-1 collagen only or type-1 collagen with either MG,
HLECM, or PLECM overlay. All data was normalized to 6β(OH) formation of RIF
Induced PHH cultured on type-1 collagen only. Values represent mean±SD of four livers.
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Figure 20. Effect of ECM overlay on CYP1A1 mRNA expression at day five. PHH
cultured on type-1 collagen or type-1 collagen with either MG, HLECM, or PLECM
overlay. Values represent mean±SD. All data was normalized to cyclophilin expression.
CT represents control (non-induced PHH).
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Figure 21. Average CYP1A1 mRNA expression of PHH cultured on type-1 collagen
only or type-1 collagen with either MG, HLECM, or PLECM overlay. All data was
normalized to CYP1A1 mRNA expression of PHH cultured on type-1 collagen only. Values
represent mean±SD of six livers.
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Figure 22. Effect of ECM overlay on CYP1A2 mRNA expression at day five. PHH
were cultured on type-1 collagen or type-1 collagen with either MG, HLECM, or PLECM
overlay. Values represent mean±SD. All data was normalized to cyclophilin expression.
CT represents control (non-induced PHH).
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Figure 23. Average CYP1A2 mRNA expression of PHH cultured on type-1 collagen
only or type-1 collagen with either MG, HLECM, or PLECM overlay. All data was
normalized to CYP1A2 mRNA expression by PHH cultured on type-1 collagen only.
Values represent mean±SD of six livers.
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Figure 24. Effect of ECM overlay on βNF-induced CYP1A1/1A2 activity (resorufin
formation) of PHH at day five. PHH were cultured on type-1 collagen or type-1 collagen
with either MG, HLECM, or PLECM overlay. Values represent mean±SD. CT represents
control (non-induced PHH).
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Figure 25. Average βNF-induced CYP1A1/1A2 activity (resorufin formation) of
PHH at day five. PHH were cultured on type-1 collagen or type-1 collagen with either MG,
HLECM, or PLECM overlay. Data normalized to resorufin formation of β-NF treated
PHH on type-1 collagen. Values represent mean±SD of six livers.
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6.0 SPECIFIC AIM 2: EFFECT OF PORCINE-DERIVED ECM SANDWICH
CONFIGURATION ON HEPATOCYTE SPECIFIC FUNCTION
Liver disease is the eleventh leading cause of mortality and results in over 25, 000 deaths
per year in the United States [5]. Allogeneic liver transplantation is the treatment of choice for
patients with end-stage liver disease but is limited by both the high cost and severe shortage of
donor organs [111]. Both whole organ xenotransplantation and hepatocyte transplantation
provide alternative therapies but have had limited clinical success [8]. Tissue engineering and
regenerative medicine approaches for the reconstruction of functional liver tissue are being
widely investigated and typically involve the use of cells, scaffolds, and bioactive factors [8,
112-114]. The present study is predicated upon the hypothesis that the scaffold or substrate upon
which hepatocytes are seeded is a critical determinant of cell phenotype and function.
In vitro culture of hepatocytes is associated with dedifferentiation, decreased hepatocyte-
specific functions [71] such as albumin secretion, hepatic transport activity, and ammonia
metabolism, and loss of hepatocyte polarity. The identification of a substrate that can maintain a
functional hepatocyte differentiation profile would represent an advancement toward
development of a tissue engineered liver substitute.
Individual ECM components or combinations of desired ECM components have been used as
substrates for hepatoycte culture systems for several decades [37, 65, 66]. While cell culture
substrates composed of individual ECM proteins such as type-1 collagen, laminin and
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fibronectin have facilitated primary rat hepatocyte attachment and maintainence of selected
liver-specific functions and hepatocyte polarity and morphology for short periods of culture,
these systems are insufficient to prevent dedifferentiation of hepatocytes [17, 28].
Conventional in vitro culture models for hepatocytes include the use of a sandwich
configuration in which hepatocytes are placed between two layers of either type-I collagen,
Matrigel (MG) or are cultured on type-1 collagen overlaid with MG [26, 66, 72, 73, 76].
Sandwich culture of primary hepatocytes maintains hepatoycte polarity and morphology better
than hepatocytes cultured on a single layer of type-I collagen or MG [35, 69, 74]. Further,
hepatocyte-specific functions, such as albumin secretion, urea synthesis and cytochrome P450
responsiveness and inducibility are enhanced when the sandwich culture model is used [15, 26,
28, 66, 73, 75, 86, 115].
The present study investigated the ability of extracellular matrix derived from porcine
liver (PLECM) to support the following primary human hepatocyte (PHH)-specific functions in
vitro: albumin secretion, hepatic transport activity and ammonia metabolism. The mRNA
expression levels of albumin, bile salt export pump (BSEP), and sodium taurocholate
cotransporting polypeptide (NTCP) were also measured.
6.1 OVERVIEW OF EXPERIMENTAL DESIGN
PHH were harvested from six human donor livers of different age groups, genders, and
medical histories. PHH viability was determined by trypan blue exclusion (Table 3). PHH were
65
cultured on either (1) adsorbed type-I collagen, (2) MatrigelTM (MG) overlaid with MatrigelTM
(MG sandwich), or (3) on adsorbed PLECM overlaid with PLECM gel (PLECM sandwich).
Albumin secretion, hepatic transport activity and ammonia metabolism were evaluated at
selected days during a ten day culture period and were used as indicators of hepatocyte
functionality (Figure 1). The mRNA levels of albumin, BSEP and NTCP were quantified.
6.2 METHODS
6.2.1 Reagents
Pepsin, sodium hydroxide, glycerol, dibasic sodium phosphate, monobasic sodium phosphate,
dexamethasome, EDTA and ethidium bromide were purchased from Sigma Chemical Co. (St.
Louis, MO). Trypsin was purchased from Gibco (Carlsbad, CA). Type-1 collagen was purchased
from Becton Dickinson (Franklin Lakes, OR). Quant-iT PicoGreen Assay was obtained from
Invitrogen-Molecular Probes (Eugene, OR). Triton-X 100 and sodium deoxycholic acid were
purchased from Spectrum (Gardena, CA). Hepatocyte Maintainence Media (HMM) was
purchased from Cambrex (Baltimore, MD). Penicillin, streptomycin and bovine calf serum were
purchased from Gibco (Carlsbad, CA). Trizol reagent was purchased from Invitrogen (Carlsbad,
CA). Hanks balanced salt solution (HBSS) was purchased from Lonza (Walkersville, MD). All
quantitative real-Time RT PCR reagents were purchased from Applied Biosystems (Foster City,
CA). Cyclophilin, albumin, BSEP and NTCP were synthesized by Applied Biosystems and the
assay identification numbers are: cyclophilin (Hs03045993_gH), albumin (Hs00910222_m1),
BSEP (Hs00184824_m1) and NTCP (Hs00161820_m1).
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6.2.2 Isolation and Preparation of PLECM Sheet Form
The methods used to isolate porcine liver ECM (PLECM) have been previously described
[28, 44, 104]. Livers were harvested from market weight pigs (~110-130kg) immediately after
euthanasia. The tissues were rinsed with tap water and frozen until used. Each liver lobe was cut
into 5 mm thick slices with a rotating blade and subjected to three separate 30 minute washes in
deionized water with mechanical agitation on an orbital shaker. The sections were then gently
massaged to aid in cell lysis and soaked in 0.02% trypsin/0.05% EDTA at 37° C for one hour.
The tissue was rinsed in deionized water and the massaging was repeated followed by
mechanical agitation of the liver sections in 3% Triton X-100 for 1 hour. The rinsing and
massaging process was repeated until all visible remnants of cellular material were removed.
The tissue sections were then mechanically agitated in 4% sodium deoxycholic acid for one hour
followed by extensive rinsing in water. The remaining decellularized connective tissue matrix
was referred to as PLECM [28].
After processing, the PLECM was immersed in a solution of 0.1% peracetic acid followed by
repeated rinses in water or phosphate buffered saline at pH 7.4. Complete decellularization was
evaluated by hematoxylin & eosin staining, nuclear (DAPI) staining, and measurement of total
DNA with Quant-iT Picogreen dsDNA Kit.
6.2.3 Preparation of PLECM Gel Form
The method used to prepare a gel form of harvested ECM has been previously described
[99]. The protocol was modified to produce a gel form of porcine-derived liver.
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First, a powdered form of PLECM was produced from sheets of PLECM. The hydrated,
sheet form of the disinfected PLECM was lyophilized overnight. Lyophilized sheets of PLECM
were cut into small pieces, then placed in a rotary knife mill (Wiley Mill) to create a particulate
form of the PLECM. Particles less than 250 micron were collected by sieve through a #60
screen.
One gram of lyophilized PLECM powder and 100 mg of pepsin (2000-3000 U/mg) were
mixed in 100 mL of 0.01 M HCl and stirred for ~72 hours at room temperature (25ºC). The final
viscous solution of digested PLECM or pre-gel solution had a pH of approximately 3.0 - 4.0.
Formation of PLECM gels was initiated by the addition of 0.1 N NaOH (1/10 of the
volume of pre-gel solution) and 10X PBS at pH 7.4 (1/9 of the volume of pre-gel solution) at
4°C. Inactivation of pepsin activity occurred when the pH was raised to 7.4. For gelation to
occur, the solution was brought to the desired volume/concentration using cold (4°C) 1X PBS at
pH 7.4 and was then placed at 37°C.
6.2.4 Preparation of Hepatocyte Culture Dishes
Type-1 collagen (0.3 mg/ml) and PLECM (0.3 mg/ml) were dried overnight to 6-well
plates in a laminar flow hood. Plates were sealed in Parafilm and stored at 4C until use. On the
day of the experiment, MG (0.3 mg/ml) was coated onto 6-well plates.
6.2.5 Isolation and Culture of Primary Human Hepatocyte
Hepatocytes were isolated from either donor livers that were not used for transplantation
or from areas of hepatic tissue that were not involved in tumor from tissue resections for cancer.
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All human subject protocols were reviewed and approved by the University of Pittsburgh
Institutional Review Boards. Significant amounts of steatosis (fat) were not observed in any of
the livers. Viability of the hepatocytes at the time of plating was greater than 76%, as measured
by trypan blue exclusion (Table 3).
PHH were isolated by a three-step collagenase perfusion of human liver [106] and seeded
in 12-well plates precoated with either adsorbed type-1 collagen, PLECM or MG at a density of
1.5x106 cells per well. Hepatocytes were seeded in HMM supplemented with 10-7 M
dexamethasome, 10-7 M insulin, 100 U/mL penicillin, 100 µg/ml streptomycin and 10% bovine
calf serum. After 4 hours of culture at 37° C, the media was replaced with serum free HMM with
the supplements listed above. After 24 hrs of culture in serum free HMM, unattached PHH were
removed by gentle agitation and the following overlays were added: MG substrates were
overlaid with 0.3 mg/ml of MG, and PLECM substrates were overlaid with 0.3 mg/ml PLECM
gel. Media was changed every 24 hours.
6.2.6 Light Microscopy
PHH were maintained in their respective culture conditions for ten days. On day ten,
PHH were imaged at 100x with a light microscope (ZEISS Axiovert 40CFL with Axiocam
MRc5, Thornwood, NY).
6.2.7 Measurement of DNA Content
Using a cell scraper, cells were harvested on ice in 150 µl cell harvest buffer containing: dibasic
sodium phosphate (11.5 g/L), monobasic sodium phosphate (2.6 g/L), EDTA (0.033 g/L), and
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20% glycerol. The cell lysates were produced by sonication and stored at –20° C. Total DNA
was quantified using the commercially available Quant-iT Picogreen dsDNA Kit according to
the manufacturer’s instructions. For each group, a minimum of two samples were used to
determine total DNA and each samples was measured in triplicate.
6.2.8 RNA Isolation
Total RNA from cell lysates was isolated using Trizol Reagent as described by the
manufacturer’s instructions. RNA concentration was determined by spectrophotometer at 260
nm. The purity of RNA was determined by spectrophotometry at 280 nm/260 nm ratio, and the
integrity checked by agarose gel electrophoresis stained with ethidium bromide. RNA was
stored at −80° until further use.
6.2.9 Quantitative Real Time RT-PCR
mRNA expression levels of Cx32 (from all donors), albumin (from donors HH1400,
HH1412, HH1423), BSEP (from donors HH1416, HH1417, HH1419, HH1423), and NTCP
(from donors HH1416, HH1417, HH1419, HH1423) were determined using TaqMan
quantitative reverse-transcriptase polymerase chain (TaqMan QRT–PCR) assays. From each
group, 2 µg of total RNA was incubated with 5 U RQ DNase, 5 µL 10 x RQ buffer in a total
volume of 10 µL at 37°C for 30 min. The samples were then incubated with 1 µL RQ DNase
Stop Solution at 65°C for 10 min. The DNAse treated RNA was then incubated with 1 µL of
random hexamer primers (100 ng/ L) at 70°C for 5 min for cDNA synthesis. cDNA generation
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continued with incubation at 37°C for 60 min with the following reagents: 1 µL dNTP (10
mmol/L of each), 5 µL MMLV 5x, and 1 µL MMLV RT for a total volume of 12 µL.
TaqMan one-step RT–PCR assays were performed with 4 ng of each RNA sample in a
final reaction volume of 72 μL prepared from TaqMan one-step RT–PCR Master Mix Reagents
Kit. Assays were performed using an Applied Biosystems’ ABI Prism 7900HT sequence
detection system. An initial RT step occurred for 30 min at 48° and was subsequently followed
by heating to 95° for 10 min followed by 40 cycles of 95° for 15 s, 60° for 1 min.
6.2.10 Measurement of Albumin Secretion
Due to limited availability of cells, conditioned media was collected from donors
HH1400, HH1412, and HH1423 on days four, six, eight, and ten, and stored at -20°C until
analysis. PHH secretion of albumin was measured using a commercially available kit (Bethel
Laboratories, Texas). At least three samples were collected from each culture condition and each
sample was measured in triplicate. All data was normalized to total DNA content.
6.2.11 Measurement of Hepatic Transport Activity
Hepatic transport activity was measured for donors HH1416, HH1417, HH1419, and
HH1423 as previously described [116]. Briefly, on day five, media was aspirated from PHH and
PHH were incubated in Hank’s balanced salt solution (HBSS) containing cations (calcium and
magnesium) for 20 minutes at 37°C. After this incubation period, the HBSS (with cations) was
aspirated and replaced with HBSS (with cations) containing 1 µM [3H]-taurocholate. Following
incubation of PHH with 1 µM [3H]-taurocholate for 20 min at 37°C, the solution was aspirated
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and the PHH were rinsed three times with ice cold HBSS (with cations). PHH were incubated
with either: (1) HBSS containing cations and (2) HBSS without cations for 20 minutes. The
media was collected and cells harvested in 1 mL NaOH/SDS solution using a cell scraper. Each
sample (0.5 mL) was then counted using a liquid scintillation counter. The harvested cell
solution was stored at -80°C until DNA quantification. At least three samples were collected
from each culture condition and each sample was measured in triplicate. All data was normalized
to total DNA content.
6.2.12 Measurement of Ammonia Metabolism
PHH metabolism of ammonia was measured on day five for donors HH1400, HH1412,
HH1419, and HH1423. Media was aspirated and PHH were incubated with 2.5 mM NH4Cl in
HMM for two hours at 37°C. The conditioned media was collected and the concentration of
NH3N was measured using a commercially available kit (Wako Pure Chemical Industries,
Tokyo, Japan). At least three samples were collected from each culture condition and each
sample was measured in triplicate. All data was normalized to total DNA content.
6.2.13 Statistical Analysis.
All values were calculated as mean ± S.D. All data was normalized to PHH cultured on
type-1 collagen. A one-way analysis of variance with a post-hoc Tukey’s multiple comparison
procedure was performed. A p value of < 0.05 was considered statistically significant and all
calculations were performed using SAS software, version 9.1 (Cary, NC)..
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6.3 RESULTS
6.3.1 Light Microscopy Images.
Hepatocytes cultured on type-1 collagen without an overlay formed flattened, confluent
cell monolayers (Figure 27A). By comparison, hepatocytes cultured in MG (Figure 27B) or
PLECM sandwich (Figure 27C) maintained a more three-dimensional-like appearance with
characteristic cuboidal shape and formed of chord-like arrays.
6.3.2 DNA Content
PHH cultured on type-1 collagen, or in either MG or PLECM sandwich had similar DNA content
(Figure 28A-F). DNA content from each culture condition was normalized to the DNA content
of PHH cultured on type-1 collagen (Figure 29).
6.3.3 Effect of ECM Sandwich Configuration on Cx32 mRNA Expression
At day five, PHH derived from donors HH1412 (Figure 30A), HH1416 (Figure 30B), and
HH1417 (Figure 30C) and cultured in PLECM sandwich had the highest levels of Cx32 mRNA
expression. PHH derived from donors HH1419 (Figure 30D) and HH1423 (Figure 30E) and
cultured in MG sandwich had the highest levels of Cx32 mRNA expression at day five.
In HH1419 and HH1423, PHH cultured in MG sandwich had the highest levels of Cx32
mRNA expression on day ten (Figures 31 A & B).
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When Cx32 mRNA data of PHH cultured in MG or PLECM sandwich were averaged
and normalized to PHH cultured on type-1 collagen, no differences in Cx32 mRNA levels were
measured (Figure 32).
6.3.4 Effect of ECM Sandwich Configuration on Alb mRNA Expression Levels
On day five, mRNA levels of albumin were determined for donors HH1400, HH1412,
and HH1423 (Figure 33A-C). Albumin mRNA levels from each culture condition were averaged
and normalized to albumin mRNA expression of PHH cultured on type-1 collagen. The
measured values for albumin mRNA levels of PHH cultured in MG or PLECM sandwich were
1.18±0.96 and 2.01±0.32 fold the value for PHH cultured on type-1 collagen (Figure 34).
6.3.5 Effect of ECM Sandwich Configuration on Albumin Secretion
Albumin secretion by PHH was measured on days four, six, eight, and ten. Due to large
variability in albumin secretion values from donor to donor, albumin secretion values were not
different between the groups regardless of the day or culture condition (Figure 35).
For donor HH1400, PHH cultured in either MG or PLECM sandwich had comparable
levels of albumin secretion at day four, which were higher than the concentration for PHH
cultured on type-1 collagen only (Figure 35A). On days six, eight and ten, PHH cultured in
PLECM sandwich had the highest levels of albumin secretion (Figure 35A).
For donor HH1412, PHH cultured in either MG or PLECM sandwich had comparable
levels of albumin secretion and the concentrations of albumin were higher than PHH cultured on
type-1 collagen alone. At days six and eight, PHH had comparable levels of albumin secretion,
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regardless of the culture condition. On day ten, PHH cultured PLECM sandwich had the highest
levels of albumin secretion (Figure 35B).
For donor HH1423, PHH had comparable levels of albumin secretion regardless of the
culture condition at day four. At days six and ten, PHH cultured in PLECM sandwich had the
highest levels of albumin secretion. At day eight, PHH cultured in either MG or PLECM
sandwich had comparable levels of albumin secretion and the concentrations were higher than
PHH cultured on type-1 collagen only (Figure 35C).
When albumin secretion was calculated as the average amount of secretion per day,
significant increases were found in the PHH cultured in either MG or PLECM sandwich
compared to the PHH cultured on type-1 collagen group. PHH in MG or PLECM sandwich
secreted 1.64±0.37 and 2.61±0.70 fold higher amounts of total albumin per day (p<0.5) (Figure
36).
6.3.6 Effect of ECM Sandwich Configuration on NTCP mRNA Expression Levels
On day five, NTCP mRNA levels were measured for donors HH1416, HH1417, HH1419,
and HH1423 (Figure 37A-D). Data from each culture condition was averaged and normalized to
PHH cultured on type-1 collagen only. PHH cultured on type-1 collagen or in either MG or
PLECM sandwich had similar NTCP mRNA expression levels (Figure 38).
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6.3.7 Effect of ECM Sandwich Configuration on BSEP mRNA Expression Levels
On day five, BSEP mRNA levels were measured for donors HH1416, HH1417, HH1419,
and HH1423 (Figure 39 A-D). For donor HH1416, due to a technical difficulty with isolation of
RNA from the PLECM group, BSEP mRNA levels were not measured. Data from each culture
condition was averaged and normalized to PHH cultured on type-1 collagen only. PHH cultured
on type-1 collagen or in either MG or PLECM sandwich had similar BSEP mRNA expression
levels (Figure 40).
6.3.8 Effect of ECM Sandwich Configuration on [3H] Taurocholate Uptake
[3H] TC uptake is an indicator of hepatic transport activity and was measured in donors
HH1416, HH1417, HH1419, and HH1423 (Figure 41A-D). [3H] TC uptake data from each
culture condition was averaged and normalized to the data from PHH cultured on type-1
collagen. The measured values for [3H] TC uptake of PHH cultured in either a MG or PLECM
sandwich were 1.34±0.16 and 1.64±0.39 fold the values of PHH cultured on type-1 collagen
(Figure 42). Trends indicate that PHH cultured with PLECM sandwich had the highest levels of
[3H] Taurocholate uptake but there was no significant difference between the groups (P=0.14).
6.3.9 Effect of ECM Sandwich Configuration on [3H] Taurocholate Efflux
[3H] TC efflux is an indicator of hepatic transport activity and was measured in donors
HH1416, HH1417, HH1419, and HH1423 (Figure 43A-D). [3H] TC efflux data from each group
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was averaged and normalized to the data from PHH cultured on type-1 collagen. PHH cultured in
MG sandwich had 0.66±0.48 fold-lower levels of [3H] TC efflux compared to PHH cultured on
type-1 collagen and PHH cultured in PLECM sandwich had 2.00±0.77 fold-higher levels of [3H]
TC efflux compared to PHH cultured on type-1 collagen (Figure 44). The PHH cultured in
PLECM sandwich had the highest levels of [3H] Taurocholate efflux and the levels were greater
than PHH cultured on type-1 collagen or in between two layers of MG (P<0.5).
6.3.10 Effect of ECM Sandwich Configuration on Ammonia Metabolism
Ammonia metabolism by PHH was measured in HH1400, HH1412, HH1419, and
HH1423 at day five (Figure 45A-D). PHH cultured in either MG or PLECM sandwich had
comparable levels of ammonia metabolism in HH1400, HH1412, and HH1423, which were
higher than the levels of PHH cultured on type-1 collagen (Figure 45A-B, D). For HH1419,
PHH cultured in PLECM had higher levels of ammonia metabolism compared to PHH cultured
on type-1 collagen or in MG sandwich (Figure 45C).
Ammonia metabolism data from each culture condition was averaged and normalized to
the data from PHH cultured on type-1 collagen. PHH cultured in MG or PLECM sandwich had
1.53±0.03 and 1.64±0.15 fold higher levels of ammonia metabolism compared to PHH cultured
on type-1 collagen (Figure 46).
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6.4 DISCUSSION
A gel form of ECM derived from porcine liver was shown to support human hepatocyte
function in vitro at levels equal to or greater than Matrigel or type I collagen. The PLECM gel
was prepared by methods designed to maintain as much of the composition of the native liver
matrix as possible. Recent studies have suggested that tissue- and organ-specific ECM can
promote site appropriate differentiation of progenitor cells [117, 118] and maintain site
appropriate phenotype in in vitro culture systems [34]. Since the ECM of each tissue and organ
is produced by the resident parenchymal cells and logically represents the ideal scaffold or
substrate for these cells, it is intuitive that a substrate composed of liver-derived ECM would be
favorable for hepatocytes.
It has recently been demonstrated that the biologic ECM scaffolds support tissue-specific
cell populations. Hepatic sinusoidal endothelial cells (SEC) maintained their differentiated
phenotype the longest when cultured on ECM derived from the liver, as compared to SEC
cultured on ECM derived from small intestine or urinary bladder [34]. These results suggest that
ECM biologic scaffolds provide a set of unique, tissue-specific signals that is dependent upon the
tissue from which an ECM is derived. The tissue-specificity of ECM scaffolds may explain why
PHH maintain their phenotype best when cultured on ECM derived from the liver compared to
PHH cultured with ECM derived from the Englbreth-Holm-Swarm mouse sarcoma (MG).
Lin et. al. compared rat hepatocytes cultured on PLECM biologic scaffolds to well
characterized hepatocyte culture models (type-1 collagen sandwich configuration or a single
layer of type-1 collagen) [28]. Hepatocytes survived up to 45 days on a sheet form of PLECM
and several liver-specific functions such as albumin synthesis, urea production, and P-450 IA1
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activity were markedly enhanced compared to the growth and metabolism of cells cultured on a
single layer of type-1 collagen.
Zeisburg et al isolated liver-derived basement membrane matrix (LBLM) from human or
bovine liver, and used the substrate for culture of human hepatocytes [35]. Human hepatocytes
adhered more efficiently to LBLM and expressed lower levels of vimentin and cytokeratin-18,
which are markers of hepatocyte dedifferentiation, compared to hepatocytes cultured on MG or
type-1 collagen. However, maintainence of liver-specific functions in vitro was not reported
[35].
Biologic scaffolds composed of ECM provide a more physiologically relevant culture
substrate compared to reconstituted ECM proteins and have unique biochemical profiles that are
dependent upon the tissue from which an ECM scaffold is derived. Minimally processed ECM
scaffolds and gels, such as PLECM, provide a combination of ECM proteins derived from the
liver that are in physiologically relevant amounts (e.g. Type-I, IV, VI, III, XI, XIX, heparin
sulfate proteoglycan, ECM-bound growth factors, laminin, biglycan, tenascin, fibronectin) [39,
44, 47].
The enhanced hepatocyte-specific functions of PHH cultured with PLECM compared to
PHH cultured with MG may be due to differences in the composition of the respective ECM.
MG contains the following ECM proteins: laminin, type IV collagen, entactin, heparan sulfate
proteoglycan, chondroiton sulfate proteoglycan, and ECM-bound growth factors [119-121].
Laminin, the most abundant ECM protein in MG, is not a major constituent of adult liver ECM
[122, 123]. Further, MG lacks several of ECM proteins found in the liver, such as fibronectin
and type-1 collagen. It is not surprising therefore, that an ECM derived from, and produced by
the cells of the liver would be a more favorable substrate for hepatocytes in vitro. The structural
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and functional proteins of an ECM scaffold provide a physical substratum for the attachment and
spatial organization of cells [124]. Well known biophysical properties such as 3-dimensional
surface topography play important roles in cell phenotype and behavior [125-129]. The 3-
dimensional surface topography of an ECM includes variation in pore diameter as well as
variation in the distances between the pores [130], surface texture [128], hydrophobicity and/or
hydrophilicity [131], and the presence or absence of a basement membrane [44]. Obviously, the
three-dimensional surface topography of the gel form of PLECM differs greatly from that of the
native liver ECM.
As the field of tissue engineering and regenerative medicine moves toward the
replacement of more complex tissues and three-dimensional organs, it is likely that more
specialized scaffolds will be needed to support multiple, functional cell phenotypes. The
findings of the present study suggest that tissue-specific ECM substrates can help maintain
appropriate cell phenotype.
6.5 CONCLUSIONS
PHH cultured in an ECM sandwich retained a more 3-D like morphology compared to
the PHH cultured on the type-1 collagen only.
Although no statistically significant mRNA levels were measured, there is a trend
towards increased mRNA levels (Cx32, Alb, NTCP, BSEP) in PHH cultured in MG or PLECM
sandwich compared to PHH cultured on type-1 collagen. An increased sample size may result in
statistical significance.
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PHH cultured with PLECM sandwich had the highest concentrations of average albumin
secretion and these concentrations were significantly higher than the levels of albumin secreted
by PHH cultured on type-1 collagen. PHH cultured in MG sandwich had lower levels of total
albumin secretion than PHH secreted in PLECM sandwich, but the concentrations were not
statistically significant.
Trends indicate that PHH cultured with PLECM sandwich had the highest levels of [3H]
Taurocholate uptake, but the [3H] Taurocholate uptake was not statistically greater than PHH
cultured on type-1 collagen or in between two layers of MG. The PHH cultured in between
PLECM had the highest levels of [3H] Taurocholate efflux and the levels were statistically
significant compared to PHH cultured on type-1 collagen or in between two layers of MG.
PHH cultured with PLECM sandwich had the highest levels of ammonia metabolism,
which were significantly higher than the ammonia metabolism of PHH cultured on type-1
collagen. While PHH cultured in PLECM sandwich metabolized higher levels of ammonia than
PHH cultured in MG sandwich, the levels were not statistically significant.
6.6 LIMITATIONS
Hepatocyte functionality was measured for only ten days. Tissue engineered liver
constructs may need to maintain the functionality and viability of a large mass of isolated PHH
for longer periods of time, even up to six weeks. Future studies should measure hepatoycte
functionality for longer periods.
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The biochemical composition of PLECM gel is unknown. A biochemical profile detailing
the structural and functional proteins present in PLECM gel would be useful, and should include
the types of collagen, glycosaminoglycans, and growth factors present.
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7.0 DISSERTATION SYNOPSIS
7.1 USE OF ECM BIOLOGIC SCAFFOLDS FOR MAINTAINENCE OF HUMAN
HEPATOCYTE-SPECIFIC FUNCTIONS IN VITRO
This work represents one of the first attempts to evaluate the maintainence of primary
human hepatocyte-specific functions on complex ECM substrates. In Specific Aim 1, no
differences in hepatoycte-specific functions were measured when comparing PHH cultured with
either MG, PLECM or HLECM overlay. From a clinical perspective, the results are appealing
because of the limited availability of human liver tissue compared to porcine liver tissue for the
manufacture of ECM scaffolds.
In Specific Aim 2, hepatocytes cultured between two layers of porcine liver ECM had
significantly higher levels of albumin secretion, hepatic transport activity, and ammonia
metabolism compared to hepatocytes cultured on collagen.
Use of xenogeneic biomaterial derived from porcine tissues does not adversely affect
human hepatocyte functions assayed, which include: DNA content, CYP450 inducibility,
albumin secretion, hepatic transport activities, and ammonia metabolism. These findings suggest
that protein and protein fragments that are leaked out or released from PLECM do not adversely
affect human hepatoycte function. Further, even if PHH cultured with PLECM show similar
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functional profiles as hepatocytes cultured with MG, PLECM is the preferred substrate because it
is derived from the liver and not a tumor cell line.
7.2 USE OF ECM BIOLOGIC SCAFFOLDS FOR HEPATIC TISSUE
ENGINEERING APPLICATIONS
Tissue engineering and regenerative medicine (TE&RM) approaches to treating liver
disease have the potential to provide temporary support with biohybrid artificial liver-assist
devices or long term therapy by replacing the diseased liver with functional tissue-engineered
constructs that utilize a combination of cells, scaffolds and bioactive factors.
The limited availability of human hepatocytes impedes advances in hepatic tissue
engineering and regenerative medicine technologies. Identification of alternative cell sources for
treatment of liver disease is an intense area of research. Proliferation of adult liver stem cells
derived from fetal liver tissue [132] or differentiation of embryonic stem cells into hepatocytes
[133, 134] are two possible cell sources. However, the alternative cells sources [135] must be
cultured in microenvironments conducive for differentiation into hepatocytes [132]. ECM
substrates that support differentiation and/or proliferation of stem cells (fetal liver,
stem/progenitor or human embryonic stem cells) into hepatocytes would provide an alternative
cell source for hepatocytes [134, 136]. Complex ECM substrates could be used alone as
substrates or as a coating for stem cell production bioreactors. Cho et al recently showed that the
use of collagen facilitated the differentiation of mouse embryonic stem cells into hepatoycte-like
cells [134]. Turner et al [132] used hyaluronic acid hydrogels to maintain pluripotent hepatic
progenitors derived from human fetal tissue in vitro.
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Table 3. Donor Information for Primary Human Hepatocyte Preparations for Specific
Aim 2.
81%NoneNDM51HH1423
87%NKCM21HH1400
76%ChemotherapyCM68HH1412
83%ChemotherapyNDF79HH1416
85%NoneNDF53HH1417
79%NoneNDM78HH1419
ViabilityDrug HistoryRacebSexaAgeDonor
HH#
ND, data not provided; NK, no known chronic drug treatment; aM, male; F, female; bC, Caucasion
Day 0 Day 104 5 86
□ □□ □
■
○
●
□ Albumin Secretion
○ BSEP Activity
■ Ammonia Metabolism
● Light Microscopy
Figure 26. Schematic of assays performed to characterize PHH phenotype.
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Figure 27. Primary cultures of human hepatocytes (PHH) maintained for ten days
under different extracellular matrix (ECM) conditions (100x). PHH were cultured (A) on
type-1 collagen; (B) between two layers of MatrigelTM; or between (C) two layers of
PLECM. Note the differences in cell morphology depending on the ECM conditions.
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Figure 28. DNA content of PHH cultured on type-1 collagen alone or in MG or
PLECM sandwich. Values represent mean±SD.
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Figure 29. Average DNA content of six livers. Data from each culture condition was
normalized to DNA content of PHH cultured on type-1 collagen. Values represent
mean±SD of six livers.
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Figure 30. Effect of ECM sandwich configuration on Cx32 mRNA expression at day
five. All data normalized to cyclophilin. Values represent mean±SD.
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Figure 31. Effect of ECM sandwich configuration on Cx32 mRNA expression at day
ten. All data normalized to cyclophilin. Values represent mean±SD.
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Figure 32. Effect of ECM sandwich configuration on Cx32 mRNA expression at
days five and ten. Data normalized to Cx32 mRNA levels of PHH cultured on type-1
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collagen at respective timepoint. Values represent mean±SD of n=5 livers for day 5 and n=2
livers for day ten.
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Figure 33. Effect of ECM sandwich configuration on albumin mRNA expression at
days five and ten. All data normalized to cyclophilin. Values represent mean±SD.
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Figure 34. Effect of ECM sandwich configuration on albumin mRNA expression at
days five and ten. Data from each culture condition was normalized to albumin mRNA of
PHH cultured on type-1 collagen. Values represent mean±SD of three livers.
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Figure 35. Effect of ECM sandwich configuration on albumin secretion of PHH
cultured on type-1 collagen or either in a MG or PLECM sandwich at days four, six, eight
and ten. Values represent mean±SD.
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Figure 36. Effect of ECM sandwich configuration on average albumin secretion of
PHH cultured in either MG or PLECM sandwich. Data from each culture condition was
normalized to average albumin secretion of PHH cultured on type-1 collagen. Values
represent mean±SD of three livers. * indicates statistically significant compared to PHH
cultured on type-1 collagen (COL) (p<0.05).
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Figure 37. Effect of ECM sandwich configuration on NTCP mRNA expression of
PHH cultured on type-1 collagen or either in a MG or PLECM sandwich at day five. All
data normalized to cyclophilin. Values represent mean±SD.
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Figure 38. Effect of ECM sandwich configuration on NTCP mRNA expression of
PHH cultured on type-1 collagen or either in a MG or PLECM sandwich at day five. Data
from each culture condition was normalized to NTCP mRNA expression of PHH cultured
on type-1 collagen. Values represent mean±SD of four livers.
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Figure 39. Effect of ECM sandwich configuration on BSEP mRNA expression of
PHH cultured on type-1 collagen or either in a MG or PLECM sandwich at day five. All
data normalized to cyclophilin. Values represent mean±SD.
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Figure 40. Effect of ECM sandwich configuration on BSEP mRNA expression of
PHH cultured on type-1 collagen or either in a MG or PLECM sandwich at day five. Data
from each culture condition was normalized to BSEP mRNA expression of PHH cultured
on type-1 collagen. Values represent mean±SD of four livers.
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Figure 41. Effect of ECM sandwich configuration on [3H] Taurocholate uptake of
PHH cultured on type-1 collagen, or either in a MG or PLECM sandwich at day five.
Values represent mean±SD.
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Figure 42. Effect of ECM sandwich configuration on [3H] Taurocholate uptake of
PHH cultured on type-1 collagen, or either in a MG or PLECM sandwich at day five. Data
from each culture condition was normalized to [3H] taurocholate uptake of PHH cultured
on type-1 collagen. Values represent mean±SD of four livers.
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Figure 43. Effect of ECM sandwich configuration on [3H] Taurocholate efflux of
PHH cultured on type-1 collagen, or either in a MG or PLECM sandwich at day five.
Values represent mean±SD. CA+ indicates PHH were cultured with cations and CA-
indicates PHH were cultured without cations.
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Figure 44. Effect of ECM sandwich configuration on [3H] Taurocholate efflux of
PHH cultured on type-1 collagen, or either in a MG or PLECM sandwich on day five.
Data from each culture condition was normalized to [3H] taurocholate efflux of PHH
cultured on type-1 collagen. Values represent mean±SD of four livers. # represents
statistically significant compared to MG (p<0.05) and * represents statistically significant
compared to type-1 collagen.
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Figure 45. Effect of ECM sandwich configuration on percentage of ammonia
metabolism by PHH cultured on type-1 collagen, or in MG or PLECM sandwich on day
five. Values represent mean±SD.
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Figure 46. Effect of ECM sandwich configuration on ammonia metabolism of PHH
cultured on type-1 collagen, or either in a MG or PLECM sandwich on day five. Data from
each group was normalized to ammonia metabolism of PHH cultured on type-1 collagen.
Values represent mean±SD of four livers. * represents statistically significant compared to
collagen.
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APPENDIX A
MAINTAINENCE OF HEPATIC SINUSOIDAL ENDOTHELIAL CELL PHENOTYPE
IN VITRO BY ORGAN-SPECIFIC EXTRACELLULAR MATRIX SCAFFOLDS
The effect of tissue-specific ECM scaffolds on maintainence of SEC phenotype in vitro
was evaluated. The porcine ECM scaffolds used for culture of hepatic SEC were derived from
small intestine (SIS-ECM), urinary bladder (UBM-ECM), or liver (LECM). Either SEC alone or
a co-culture of SEC plus hepatocytes were cultured on the ECM.
A.1 INTRODUCTION
Sinusoidal endothelial cells (SEC) are difficult to culture in vitro. SEC are highly
specialized endothelial cells characterized by the presence of fenestrations organized into sieve
plates, which permit the selective passage of proteins and metabolites. Differentiated SEC have
sieve plates, express anti-rat hepatic sinusoidal endothelial cells mouse IgG monoclonal antibody
(SE-1) [137-139], and do not express CD31. CD31 is a marker of both macro- and microvascular
endothelial cells and is expressed by dedifferentiating SEC [140].
SEC derived from GFP-expressing rats were cultured on ECM derived from either
porcine small intestinal submucosa (SIS-ECM), urinary bladder (UBM-ECM), or liver (LECM)
for seven days. Either SEC alone or a co-culture of SEC plus PHH were cultured on the ECM.
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The effect of the ECM substrate upon SEC dedifferentiation was evaluated by scanning electron
microscopy (SEM) (presence or absence of fenestrations and sieve plates) and confocal
microscopy (expression of SE-1 and CD31).
A.2 METHODS
A.2.1 Overview of Experimental Design
Rat derived liver SEC were cultured alone or were co-cultured with rat derived
hepatocytes for one, three or seven days on one of five different substrates: collagen type I,
untreated glass slides, ECM derived from liver (L-ECM), ECM derived from urinary bladder
(UBM-ECM), or ECM derived from small intestinal submucosa (SIS-ECM). The effect of the
ECM substrate upon SEC differentiation was evaluated by: (1) scanning electron microscopy
(SEM) to view the presence of fenestrations and sieve plates and (2) confocal microscopy for
expression of SE-1, a marker of SEC differentiation [137-139], and (3) confocal microscopy for
CD31, a marker of hepatic SEC dedifferentiation [140].
A.2.2 Isolation and Preparation of ECM
The liver, urinary bladder, and small intestine were harvested from market weight pigs
(~110-130kg) immediately after euthanasia. The tissues were rinsed with tap water and frozen
until used.
The methods used to isolate liver ECM (L-ECM) have been previously described [28,
44]. Briefly, each liver lobe was cut into 5 mm slices with a rotating blade and subjected to three
separate thirty-minute washes in deionized water with mechanical agitation on an orbital shaker.
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The sections were then gently massaged to aid in cell lysis and soaked in 0.02% trypsin/0.05%
EDTA (Gibco; Carlsbad, CA) at 37° C for one hour. The tissue was then rinsed in deionized
water and the massaging was repeated followed by mechanical agitation of the liver sections in
3% Triton X-100 (Spectrum; Gardena, CA). The rinsing and massaging process was repeated
until all visible remnants of cellular material were removed. The tissue sections were then
mechanically agitated in 4% sodium deoxycholic acid (Spectrum) for one hour followed by
extensive rinsing in water. The remaining decellularized connective tissue matrix was referred to
as L-ECM [28].
A detailed description of the isolation and preparation of UBM-ECM has been previously
described [44, 141]. The urothelial cell layer was removed from porcine urinary bladder by
immersion in deionized water on a mechanical shaker for 60 minutes. The tunica serosa, tunica
muscularis externa, tunica submucosa and most of the muscularis mucosa were removed from
the urinary bladder tissue by manual scraping. The remaining layers, which consisted primarily
of basement membrane and tunica (lamina) propria, were referred to as UBM-ECM.
The preparation of SIS-ECM has also been previously described [44, 102, 142]. The
luminal portion of the tunica mucosa, including the majority of the lamina propria, was removed,
and the entirety of the serosa and tunica muscularis externa were removed by manual scraping.
The remaining tunica submucosa, muscularis mucosa and stratum compactum of the lamina
propria was referred to as SIS-ECM.
After processing, all tissues were then immersed in a solution of 0.1% peracetic acid
followed by repeated rinses in water or phosphate buffered saline at pH 7.4. The resulting
decellularized and disinfected ECM was terminally sterilized with ethylene oxide [105].
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A.2.3 Isolation and culture of hepatocytes and SEC
Transgenic adult Sprague-Dawley rats carrying the enhanced green fluorescence protein
(EGFP) gene were used as the source of all cells in this study [143]. The procedures were
approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh
and were conducted in accordance with the guidelines of the National Institutes of Health for the
humane care of research animals. The rats weighed approximately 200 g at time of sacrifice for
cell harvest.
Hepatocytes and nonparenchymal cells (NPC), which include SEC, were isolated by two-
stage collagenase perfusion as previously described [144]. After removal of undigested tissues,
hepatocytes were separated from NPC by filtration differential centrifugation [145].
To purify SEC from NPC, SEC were isolated by magnetite beads coated with a charged
50 nm cationic, polyethyleniemine-coated colloidal, a specific antibody against rat SEC
membrane surface antigen (Chemicell, Berlin, Germany) [146]. The isolated SEC were
resuspended in EGM-2 media (Clonetics BulletKit).
Typically, 200 to 300 million hepatocytes were isolated with 85 to 95% viability as
assessed by exclusion of trypan blue dye. Hepatocytes were then cultured in hepatocyte growth
medium (HGM). Basal HGM (Dulbecco’s Modified Eagle Medium (DMEM) medium, HEPES,
glutamine, and antibiotics (Gibco; Carlsbad, CA) supplemented with bovine albumin (2.0 g/L),
glucose (2.25 g/L), galactose (2.0 g/L), ornithine (0.1 g/L), proline (0.030 g/L), nicotinamide
(0.305 g/L), ZnCl2 (0.544 g/L), ZnSO4:7H20 (0.750 g/L), CuSO4:5H20 (0.20 g/L), MnSO4 (0.025
g/L), glutamine (5 mmol/L), and dexamethasome (10-7 mol/L) (Sigma Chemical Company; St.
Louis, MO) was mixed and sterile filtered through a 0.22 μm low-protein-binding filter system,
stored at 4° C, and used within four weeks. Insulin, transferrin and selenium were added to the
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basal HGM just before use, for a final concentration of 5 µg/ml Insulin, 5 ng/ml transferrin, and
5 ng/ml selenium [147].
All experiments involved the culture of either SEC only or a co-culture of SEC plus
hepatocytes upon the following substrates: untreated glass coverslips (Fisher Scientific;
Pittsburgh, PA), collagen type I (BD Biosciences; Bedford, MA), the luminal surface of SIS-
ECM (i.e. stratum compactum surface), the luminal surface of UBM-ECM (i.e. basement
membrane surface) or L-ECM. For cells cultured on ECM substrates, untreated polystyrene 6
well microplates were used (Evergreen Scientific; Los Angeles, CA). The seeding density for
the co-culture experiments was 0.7x106 hepatocytes:1x106 SEC/cm2. The SEC only group were
seeded at 1x106 SEC/cm2 in Clonetics EBM-2 medium with EGM-2 supplements (Cambrex,
E.Rutherford, NJ), while the SEC and hepatocyte co-culture media formulation was 50%
HGM/50% EGM-2. As a control to determine the effects of the co-culture media on SEC
phenotype, SEC were also cultured without hepatocytes on the three different ECM in 50%
HGM/50% EGM-2. Cells were seeded at 1x106 cells/cm2 of substrate surface area and cells
were examined using scanning electron microscopy at one, three and seven days after seeding.
A.2.4 Scanning Electron Microscopy.
Samples were fixed overnight with 2.5% glutaraldehyde in phosphate buffered saline
(PBS). After three PBS washes, tissue was dehydrated through a graded series of ethanol washes
followed by critical point drying using an Emscope CPD 750. Samples were sputter coated with
a 7-nm layer of gold-palladium (Cressington 108 sputter coater) and visualized at a voltage of 12
kV using a JEM 6335F field emission gun SEM (JEOL, Peabody, MA).
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For each experimental group, three samples were examined at each time point (days one,
three, and seven). Cells were randomly selected for imaging by starting at a preselected point in
the lower left quadrant of the 1 cm2 sample and moving to subsequent preselected areas in a
clockwise manner taking approximately 12 photomicrographs for each sample. Representative
images were selected for inclusion in this report.
A.2.5 Immunofluorescence for SE-1 and CD31
Hepatocytes cultured on ECM scaffolds were fixed in 2% paraformaldehyde in PBS at
room temperature for 10 minutes. Fixed samples were washed 3 times in PBS and permeabilized
in 0.1% Triton-X for 20 minutes at room temperature. Following cell permeabilization, samples
were washed 3 times with bovine 0.5% serum albumin (BSA) in PBS and were then blocked
with 2% BSA in PBS for 1 hour. Following 3 washes in 0.5% BSA in PBS, samples were
incubated for 1 hr at room temperature: mouse anti-rat CD31 (1:250 in 0.5% BSA; Serotec,
Raleigh, NC) or SE-1 (1:100 in 0.5% BSA; Immuno-Biological Laboratories, Minneapolis, MN).
Following 3 washes with BSA in PBS, samples were incubated at room temperature for 1 hour
with goat anti-mouse Cy3 conjugated secondary (1:1000 in 0.5% BSA;
JacksonImmunoResearch, West Grove, PA). After incubation in the secondary antibody, samples
were then placed in PBS and incubated with Hoeschts dye (bizBenzamide, 1 mg/mL in PBS) for
30 seconds to stain nuclear DNA. Finally, the samples were washed 3 times in PBS and stored at
4°C for a maximum of 24 hours before imaging. Experiments were performed in triplicate.
Samples were imaged using an inverted Olympus Fluoview 1000 microscope (Olympus).
Representative images were selected for inclusion in this report.
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A.3 SEM RESULTS
A.3.1 Culture of Sinusoidal Endothelial Cells on ECM Substrates
After one day of culture on SIS-ECM, no sieve plates were present on SEC. Only a few
fenestrations were present as well as large holes at day one (Figure 47A). Large holes were
present and no fenestrations were present at day three (figure not shown) and day seven (Figure
47B).
When SEC were cultured on UBM-ECM, there were few sieve plates and fenestrations at
day one (Figure 47C), large holes were present at day three (Figure 47D) and after seven days of
culture, a confluent monolayer of dedifferentiated SEC containing no fenestrations or sieve
plates was observed (not shown).
After one and three days of culture on LECM, the SEC had fenestrations that were
organized into sieve plates, characteristic of differentiated SEC (Figures 48A&B). Large holes
and no fenestrations were present at day seven (Figure 48C).
A.3.2 Co-culture of Sinusoidal Endothelial Cells and Hepatocytes on ECM substrates
While the SEC co-cultured with hepatocytes on SIS-ECM (Figure 49A) and UBM-ECM
(Figure 49C) maintained fenestrations that were organized in sieve plates for at least one day, the
appearance of sieve plates was not as frequent when compared to the SEC co-cultured with
hepatocytes on LECM. After three days (Figures not shown) and seven days of culture, no
fenestrations were present on SEC co-cultured with hepatocytes on either SIS-ECM (Figure 49B)
or UBM-ECM (Figure 49D).
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At all time points, the SEC co-cultured with hepatocytes on LECM maintained the
greatest amount of fenestrations and these fenestrations were organized in characteristic sieve
plates. At day one, many sieve plates were present (Figure 49E). At three days, sieve plates were
still present only in those SEC that were co-cultured with hepatocytes upon the LECM substrate
(not shown) and by seven days, only the SEC co-cultured with hepatocytes on LECM maintained
a fenestrated phenotype (Figure 49F).
When SEC only were cultured on either type-1 collagen, UBM-ECM, or SIS-ECM, SEC
showed signs of dedifferentiation after only one day. In contrast, SEC only cultured on LECM
maintained their differentiated phenotype for at least three days, indicated by the presence of
many fenestrations on SEC surface. When SEC were co-cultured with hepatocytes on any of the
ECM scaffolds, the SEC maintained a near normal fenestrated phenotype for at least one day.
However, SEM revealed that the shape, size, frequency and organization of the fenestrations
varied greatly depending on ECM source. At all time points, SEC co-cultured with hepatocytes
on LECM maintained the greatest degree of differentiation.
A.4 CONFOCAL MICROSCOPY RESULTS
A.4.1 Culture of Sinusoidal Endothelial Cells on ECM substrates
After one day of culture, SE-1 was minimally expressed in SEC cultured on SIS-ECM
(Figure 50A) and UBM-ECM (Figure 50B), and SE-1 was expressed most intensely in the SEC
cultured on LECM (Figure 50C). After three days of culture, SE-1 was minimally expressed in
SEC cultured on SIS-ECM (Figure 51A) and UBM-ECM (Figure 51B), compared to SEC on
LECM (Figure 51C).
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On day one, SEC cultured on SIS-ECM (Figure 52A) and UBM-ECM (Figure 52B) had
CD31 expression localized in the cytoplasm of SEC with some expression of CD31 at cell-cell
junctions, findings consistent with dedifferentiation. In contrast, SEC cultured on LECM for
one day (Figure 52C) expressed minimal amounts of CD31 in the cytoplasm and expressed no
CD31 at the cell surface.
After three days of culture on SIS-ECM (Figure 53A) and UBM-ECM (Figure 53B), SEC
had extensive expression of CD31 at the cell-cell junctions, indicative of SEC dedifferentiation.
After three days of culture on LECM (Figure 53C), SEC expressed CD31 in the cytoplasm and at
some cell-cell junctions. At day seven of culture, SEC on LECM expressed both SE-1 (Figure
54A) and CD31 (Figure 54B).
A.5 CONCLUSIONS
The effect of organ-specific ECM scaffolds on maintainence of SEC phenotype was
evaluated. Hepatic SEC maintained their differentiated state the longest when cultured on ECM
derived from the liver compared to ECM derived from either the UBM-ECM or the SIS-ECM.
SEC cultured on LECM had markedly increased fenestrations, increased expression of SE-1 and
decreased expression of CD31 compared with SEC cultured on SIS-ECM or UBM-ECM. The
present study suggests liver-derived ECM provides a unique set of tissue-specific signals that
contribute to the maintenance of a site-specific, fenestrated phenotype for hepatic SEC.
As the field of tissue engineering and regenerative medicine moves toward the
replacement of more complex tissues and three-dimensional organs, it is likely that more
specialized scaffolds will be needed to support multiple, functional cell phenotypes in site-
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specific, unique three-dimensional arrangements. The findings of the present study suggest that
tissue-specific ECM substrates can help maintain appropriate cell phenotype.
A.6 SUMMARY
The biochemical composition of ECM varies throughout the body and is dependent on
the resident cells of the organ to tailor the ECM so that it supports the needs of the highly
specialized cell populations residing within a tissue or organ. For example, cardiac fibroblasts
produce a highly specialized ECM that supports the structural and functional requirements of
heart. In this study, we showed that after decellularization, the ECM retains its tissue-specificity.
The results of the tissue-specific ECM study laid the foundation of this dissertation. Since
the above study showed an tissue-specific effect on cell phenotype, the question was asked “Do
ECM scaffolds have a species-specific effect on cell phenotype?” In other words, would an ECM
scaffold derived from a human liver better maintain the phenotype of cells derived from human
liver compared to an ECM scaffold derived from porcine liver?
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Figure 47. SEM of SEC cultured on SIS-ECM at day 1 (A) and at day 7 (B) and on
UBM-ECM at (C) day one and at (D) day three (5000x). Arrows indicate cell boundaries
▼ indicate representative fenestrations, * indicate representative sieve plates.
115
Figure 48. SEM of SEC cultured on LECM at (A) day one, (B) day three and (C)
day seven (5000x). Arrows indicate cell boundaries. ▼ indicate representative fenestrations 
and * indicate representative sieve plates.
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Figure 49. SEM of SEC co-cultured with hepatocytes on SIS-ECM at (A) day one
and (B) day seven. SEM of SEC and hepatocytes on UBM-ECM at (C) day one and at (D)
day seven. SEM of SEC and hepatocytes on LECM at (E) day one and (F) day seven
(5000x). Arrows indicate cell boundaries, ▼ indicate representative fenestrations, and * 
indicate representative sieve plates.
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Figure 50. Expression of SE-1 at day one. Confocal microscopy images of SEC
cultured on (A) SIS-ECM, (B) UBM-ECM, and (C) LECM at day one (400x). Red
indicates expression of SE-1, green indicates green fluorescent protein (GFP), and blue
indicates nuclear stain. Yellow is co-localization of red and green. Purple results from the
autofluorescence of the ECM scaffold.
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Figure 51. Expression of SE-1 at day three. Confocal microscopy images of SEC
cultured on (A) SIS-ECM (400x), (B) UBM-ECM (400x) and (C) LECM (600x) scaffolds at
day three. Red indicates expression of SE-1, green indicates expression of GFP, and blue
indicates nuclear stain. Yellow is co-localization of red and green.
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Figure 52. Expression of CD31 at day one. Confocal microscopy images of SEC
cultured on (A) SIS-ECM, (B) UBM-ECM and (C) LECM at day one (400x). Red indicates
expression of CD-31, green indicates expression of GFP, and blue indicates nuclear stain.
Yellow is co-localization of red and green.
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Figure 53. Expression of CD31 at day three. Confocal microscopy images of SEC
cultured on (A) SIS-ECM, (B) UBM-ECM, and (C) LECM at day three (400x). Red
indicates expression of CD-31, green indicates expression of GFP, and blue indicates
nuclear stain. Yellow is co-localization of red and green.
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Figure 54. Expression of SE-1 and CD31 at day seven. Confocal microscopy images
of SEC cultured on LECM scaffolds expressing (A) SE-1 and (B) CD31 at day 7 (600x).
Red indicates expression of (A) SE-1 or (B) CD31, green indicates expression of GFP, and
blue indicates nuclear stain. Yellow is co-localization of red and green.
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APPENDIX B
DECELLULARIZATION OF WHOLE ORGAN SCAFFOLDS
B.1 INTRODUCTION
Tissue engineering and regenerative medicine efforts to reconstruct functional tissue have
been limited to skin, lower urinary tract, and musculoskeletal tissues. More complex organs
such as the heart, kidney, liver, and pancreas have had limited success due to the inability of
existing substrate materials to support proliferation and differentiation of specialized cells such
as cardiomyocyte, hepatocytes, pancreatic exocrine and endocrine cells, and the various ductular
epithelial cells of the kidney.
Tissue-specific extracellular matrix (ECM) biological scaffolds have been shown to
support the viability of functional, differentiated hepatocyte in vitro [28, 148]. In these studies,
the ECM scaffolds used were limited to a two-dimensional form and the native liver architecture
and vasculature was not preserved. Use of an intact, whole organ ECM, which maintains the
three-dimensionality of the native liver, could provide a more optimal hepatocyte culture
environment compared to hepatocytes cultured on the sheet or gel form of LECM.
The objective of the present study was to isolate a three-dimensional form of liver ECM
and to evaluate the ability of the intact, three-dimensional form to maintain primary hepatocyte-
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specific functions in vitro. The project is predicated upon the hypothesis that the scaffold or
substrate upon which primary human hepatocytes are seeded is a critical determinant of cell
phenotype and function.
B.2 METHODS
B.2.1 Development of Whole Organ Perfusion Bioreactor
In this closed looped system, a peristaltic pump transports the perfusate from the media
reservoir into the intact rat liver at a rate of 20 ml/min (Figure 55).
B.2.2 Decellularization of Whole Intact Rat Liver
Adult Sprague-Dawley rats were used for isolation of hepatocytes and weighed
approximately 200 g at time of sacrifice. The procedures were approved by the Institutional
Animal Care and Use Committee at the University of Pittsburgh and were conducted in
accordance with the guidelines of the National Institutes of Health for the humane care of
research animals.
Livers were perfused using a decellularization solution to remove existing cellular
components. For delivery of solutions to the rat liver, a catheter was inserted into the inferior
vena cava below the liver. The inferior vena cava above the liver was tied off. The rat liver was
perfused with deionized water overnight. The solution was changed at least three times. The rat
liver was then perfused with a solution containing 0.02% trypsin/0.05% EDTA at 37° C for one
124
hour. The liver was then perfused with deionized water for 2 hours. Following perfusion with the
deionized water, the liver was perfused overnight with sterile PBS. The next day, the liver was
perfused with deionized water for 1 hour followed by perfusion with a 3% Triton X-100 for one
hour. The liver was then perfused overnight with PBS. The next perfusate contained 4% sodium
deoxycholic acid for one hour followed by rinsing in water a minimal of three times. The rat
liver was then perfused overnight with PBS followed by perfusion with 0.1% peracetic acid
followed for 2 hours. After decellularization, the intact rat liver ECM was perfused with at pH
7.4 overnight (Figure 56A). The phosphate buffered saline solution was changed a minimum of
three times. All solutions were sterile filtered with a 0.22 µm filter prior to use.
B.2.3 Hepatocyte Isolation and Culture
Adult Sprague-Dawley rats were used for isolation of hepatocytes and weighed
approximately 200 g at time of sacrifice. The procedures were approved by the Institutional
Animal Care and Use Committee at the University of Pittsburgh and were conducted in
accordance with the guidelines of the National Institutes of Health for the humane care of
research animals.
Hepatocytes were isolated by two-stage collagenase perfusion as previously described
[144]. After removal of undigested tissues, hepatocytes were separated from NPC by filtration
differential centrifugation [145].
Typically, 200 to 300 million hepatocytes were isolated with 85 to 95% viability as
assessed by exclusion of trypan blue dye. Hepatocytes were then cultured in hepatocyte growth
medium (HGM). Basal HGM (Dulbecco’s Modified Eagle Medium (DMEM) medium, HEPES,
glutamine, and antibiotics (Gibco; Carlsbad, CA) supplemented with bovine albumin (2.0 g/L),
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glucose (2.25 g/L), galactose (2.0 g/L), ornithine (0.1 g/L), proline (0.030 g/L), nicotinamide
(0.305 g/L), ZnCl2 (0.544 g/L), ZnSO4:7H20 (0.750 g/L), CuSO4:5H20 (0.20 g/L), MnSO4 (0.025
g/L), glutamine (5 mmol/L), and dexamethasome (10-7 mol/L) (Sigma Chemical Company; St.
Louis, MO) was mixed and sterile filtered through a 0.22 μm low-protein-binding filter system,
stored at 4° C, and used within four weeks. Insulin, transferrin and selenium were added to the
basal HGM just before use, for a final concentration of 5 µg/ml Insulin, 5 ng/ml transferrin, and
5 ng/ml selenium [147].
Hepatocytes were injected into the perfusion system for delivery to the acellular rat liver
by 22-gauge syringe with a flow rate of 2 ml/min. Approximately 140 million hepatocytes were
perfused into the rat liver and were cultured for 72 hours (Figure 56B).
B.2.4 Hematoxylin and Eosin Staining
Hematoxylin and eosin staining was performed on native rat liver and acellular, intact rat liver.
B.2.5 Scanning Electron Microscopy
Samples were fixed overnight with 2.5% glutaraldehyde in phosphate buffered saline
(PBS). After three PBS washes, tissue was dehydrated through a graded series of ethanol washes
followed by critical point drying using an Emscope CPD 750. Samples were sputter coated with
a 7-nm layer of gold-palladium (Cressington 108 sputter coater) and visualized at a voltage of 12
kV using a JEM 6335F field emission gun SEM (JEOL, Peabody, MA).
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For each experimental group, three samples were examined. Cells were randomly
selected for imaging by starting at a preselected point in the lower left quadrant of the 1 cm2
sample and moving to subsequent preselected areas in a clockwise manner taking approximately
12 photomicrographs for each sample. Representative images were selected for inclusion in this
report.
B.2.6 Immunofluorescence
Hepatocytes cultured within intact LECM were fixed in 2% paraformaldehyde in PBS at
room temperature for 10 minutes. Fixed samples were washed three times in PBS and
permeabilized in 0.1% Triton-X for 20 minutes at room temperature. Following cell
permeabilization, samples were washed three times PBS and then were incubated for 1 hr at
room temperature with rhodamine phalloidin (F-actin) (1:250 in 0.5% BSA; Molecular Probes,
Carlsbad, CA). Samples were washed three times in PBS and then incubated with Hoeschts dye
in PBS (bizBenzamide, 1 mg/mL in PBS) for 30 seconds to stain nuclear DNA. Finally, the
samples were washed three times in PBS and stored at 4°C for a maximum of 24 hours before
imaging. Experiments were performed in triplicate. Samples were imaged using an inverted
Olympus Fluoview 1000 microscope (Olympus). Representative images were selected for
inclusion in this report.
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B.3 RESULTS
Histological examination of native rat liver showed typical morphology of native rat liver
(Figure 57A). Hematoxylin and eosin staining of acellular rat liver ECM confirmed the absence
of intact cellular components (Figure 57B). Histological examination of intact, rat liver ECM
seeded with rat hepatocytes showed the presences of hepatocytes (Figure 57C).
SEM images of native rat liver revealed a fibrous structure interspersed with cell (Figure
58A). SEM images of acellular whole organ rat liver ECM confirmed the absence of cells and
revealed a fibrous structure similar to native liver tissue ultrastructure (Figure 58B). SEM
images of whole organ rat liver ECM seeded with rat hepatocytes revealed the presence of
hepatocytes cultured within the ECM (Figure 58C).
Factin and nuclear staining revealed that the hepatocytes remained within the vasculature
of the decellularized, whole organ rat liver ECM. (Figure 59).
B.4 SUMMARY
Preliminary results show that whole rat liver decellularization can be achieved and that
three-dimensional rat liver ECM is an extremely complex scaffold that is similar to that of the
native hepatic architecture.
A common regenerative medicine strategy for tissue and organ reconstruction involves the
seeding of a scaffold with cells harvested from the tissues or organs of interest, followed by
eventual placement of the cell-scaffold combination to the intended in vivo location. Isolation of
an acellular, three-dimensional form of liver ECM that could be reseeded with allogeneic cells
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and implanted into a patient would represent a major advancement in tissue engineering and
regenerative medicine.
B.5 FUTURE DIRECTIONS
Hepatocyte functionality will be evaluated by measurement of albumin secretion,
ammonia and urea metabolism, CYP450 3A4 and CYP1A1/1A2 inducibility and activity, bile
salt export pump activity (BSEP) and expression of connexin 32. The following mRNA levels
will be measured: cyclophilin, albumin, CYP3A4, CYP1A1, CYP1A2, and connexin 32, BSEP
and NTCP. All data will be normalized to total DNA content. Hepatocytes will be cultured for at
least one week.
Figure 55. Schematic of perfusion bioreactor.
129
Figure 56. (A) Image of acellular, intact rat liver ECM. (B) Image of intact rat liver
ECM seeded with rat hepatocytes.
Figure 57. Hematoxylin and eosin staining of (A) native rat liver (200x), (B)
acellular, intact rat liver ECM (200x), and (C) intact rat liver ECM seeded with rat
hepatocytes (400x).
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Figure 58. Scanning electron micrograph of (A) native rat liver (330x), (B) acellular
rat liver ECM (500x), (C) intact rat liver ECM seeded with rat hepatocytes (330x).
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Figure 59. F-actin localization (red) and nuclear staining (blue) of rat hepatocytes
seeded within whole organ rat liver ECM.
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